Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SUNKO Audit Report / Information 2025

May 14, 2026

51901_rns_2026-05-14_1be758ec-6b34-49d7-a4ee-aee863c55996.pdf

Audit Report / Information

Open in viewer

Opens in your device viewer

1721

SUNKO INK CO., LTD.
PARENT COMPANY ONLY
FINANCIAL STATEMENTS
WITH REPORT OF INDEPENDENT ACCOUNTANTS
FOR THE YEARS ENDED
31 DECEMBER 2025 AND 2024

Address: 5F., No. 229, Zhongxing St., West Dist., Taichung City 403022, Taiwan R.O.C.
Telephone: 886-4-23215616

Notice to readers:
The reader is advised that these financial statements have been prepared originally in Chinese. In the event of a conflict between these financial statements and the original Chinese version or difference in interpretation between the two versions, the Chinese language financial statements shall prevail.

1


2

AUDIT REPORT OF INDEPENDENT ACCOUNTANTS

English Translation of a Report Originally Issued in Chinese

Independent Auditors' Report

To SUNKO INK CO., LTD.

Opinion

We have audited the accompanying parent company only balance sheets of SUNKO INK CO., LTD. (the "Company") as of 31 December 2025 and 2024, and the related parent company only statements of comprehensive income, changes in equity and cash flows for the years ended 31 December 2025 and 2024, and notes to the parent company only financial statements, including the summary of material accounting policies (together "the parent company only financial statements").

In our opinion, the parent company only financial statements referred to above present fairly, in all material respects, the parent company only financial position of the Company as of 31 December 2025 and 2024, and their parent company only financial performance and cash flows for the years ended 31 December 2025 and 2024, in conformity with the requirements of the Regulations Governing the Preparation of Financial Reports by Securities Issuers.

Basis for Opinion

We conducted our audits in accordance with the Regulations Governing Financial Statement Audit and Attestation Engagements of Certified Public Accountants and the Standards on Auditing of the Republic of China. Our responsibilities under those standards are further described in the Auditors' Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the Norm of Professional Ethics for Certified Public Accountant of the Republic of China (the "Norm"), and we have fulfilled our other ethical responsibilities in accordance with the Norm. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Key Audit Matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of 2025 the parent company only financial statements. These matters were addressed in the context of our audit of the parent company only financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.


Impairment of notes and accounts receivable

As of 31 December 2025, the Company’s gross notes and accounts receivable and allowance for loss amounted to $236,263 thousand and $42 thousand respectively. Net notes and accounts receivable accounted for 8% of total assets which was material to the Company. Since the collection of notes and accounts receivable is the key factor in the working capital management of the Company, and the adoption of provision policy requires significant management judgement, we therefore determined this a key audit matter.

Our audit procedures included, but not limited to, understanding and testing the effectiveness of internal control over accounts receivable; assessing the reasonableness of allowance for loss policy, including understanding related information to evaluate expected credit loss ratio according to historical experience, current market and future economic outlook expected; investigating accounts receivable details, recalculating the reasonableness of allowance for loss based on the expected credit companies, and based on the expected loss rate by management assessment, reevaluating the reasonableness of loss provisioning of accounts receivable. We also assessed the adequacy of disclosures related to accounts receivable. Please refer to Notes 5 and 6 of the financial statements.

Inventory valuation

As of 31 December 2025, the Company’s net inventories amounted to $601,706 thousand, accounting for 20% of the total assets. The estimation of allowance for inventory valuation loss and obsolescence loss was based on inventories of the raw materials and finished goods. The estimation basis of inventory valuation based on the effect of products physical characteristic on quality, and the demand of products within a particular period in the future, the allowance for inventory valuation loss and obsolescence loss could be affected by management judgement. We therefore determined this a key audit matter.

Our audit procedures included, but were not limited to: assessing the effectiveness of obsolescence inventory internal control and the inventory valuation policy established by management, assessing stocktaking plan and selecting important storage locations to observe inventory counts to ensure quantities and status; obtaining inventory aging intervals to test whether the aging reports were reasonable; testing the unit cost and selling prices of inventories, sampled related certificates of purchases and sales to access the reasonableness of the net realizable value of inventories.

We also assessed the adequacy of the disclosures related to inventories in Notes 5 and 6.


4

Responsibilities of Management and Those Charged with Governance for the Parent Company Only Financial Statements

Management is responsible for the preparation and fair presentation of the parent company only financial statements in accordance with the requirements of the Regulations Governing the Preparation of Financial Reports by Securities Issuers and International Financial Reporting Standards, International Accounting Standards, Interpretations developed by the International Financial Reporting Interpretations Committee or the former Standing Interpretations Committee as endorsed and became effective by Financial Supervisory Commission of the Republic of China and for such internal control as management determines is necessary to enable the preparation of the parent company only financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the parent company only financial statements, management is responsible for assessing going concern of the Company, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.

Those charged with governance, including audit committee, are responsible for overseeing the financial reporting process of the Company.

Auditors' Responsibilities for the Audit of the Parent Company Only Financial Statements

Our objectives are to obtain reasonable assurance about whether the parent company only financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors' report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with auditing standards in the Republic of China will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of the parent company only financial statements.

As part of an audit in accordance the Standards on Auditing of the Republic of China, we exercise professional judgment and professional skepticism throughout the audit. We also:


  1. Identify and assess the risks of material misstatement of the parent company only financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

  2. Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the internal control of the Company.

  3. Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.

  4. Conclude on the appropriateness of management’s use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the ability to continue as a going concern of the Company. If we conclude that a material uncertainty exists, we are required to draw attention in our auditors’ report to the related disclosures in the parent company only financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditors’ report. However, future events or conditions may cause the Company to cease to continue as a going concern.

  5. Evaluate the overall presentation, structure and content of the parent company only financial statements, including the accompanying notes, and whether the parent company only financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

  6. Obtain sufficient appropriate audit evidence regarding the financial information of the entities or business activities within the Company to express an opinion on the parent company only financial statements. We are responsible for the direction, supervision and performance of the company audit. We remain solely responsible for our audit opinion.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

5


We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of 2025 the parent company only financial statements and are therefore the key audit matters. We describe these matters in our auditors’ report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.

/s/ Ke,Ya Ting

/s/Huang, Tzu Ping

Ernst & Young, Taiwan

6 March 2026

Notice to Readers

The accompanying parent company only financial statements are intended only to present the parent company only financial position, results of operations and cash flows in accordance with accounting principles and practices generally accepted in the Republic of China and not those of any other jurisdictions. The standards, procedures and practices to audit such parent company only financial statements are those generally accepted and applied in the Republic of China.

Accordingly, the accompanying parent company only financial statements and report of independent auditors are not intended for use by those who are not informed about the accounting principles or auditing standards generally accepted in the Republic of China, and their applications in practice. As the financial statements are the responsibility of the management, Ernst & Young cannot accept any liability for the use of, or reliance on, the English translation or for any errors or misunderstandings that may derive from the translation.

6


English Translation of Parent Company Only Financial Statements Originally Issued in Chinese
SUNKO INK CO., LTD.
PARENT COMPANY ONLY BALANCE SHEETS
31 December 2025 and 2024
(Expressed in Thousands of New Taiwan Dollars)

Assets Notes As of 31 December
2025 2024
Current assets
Cash and cash equivalents 4,6(1) $504,065 $450,669
Financial assets measured at amortized cost - current 4,6(2) $115,810 -
Notes receivable, net 4,6(12) 7,542 8,143
Accounts receivable, net 4,6(3)&(12) 236,321 375,251
Inventories, net 4,6(4) 601,706 776,716
Prepayments 44,891 72,991
Other current assets 12 2,236 1,902
Total current assets 1,512,571 1,685,672
Non-current assets
Financial assets at fair value through other comprehensive income 4,13 47,003 110,515
- non-current
Financial assets measured at amortized cost - non-current 4,6(2)&8 2,800 2,800
Investments accounted for under the equity method 4 1,624 1,615
Property, plant and equipment 4,6(5)&8 1,302,926 1,379,973
Right-of-use assets 4,6(13)&7 83,868 92,039
Intangible assets 4 2,678 2,059
Deferred tax assets 4,6(17) 95,494 84,133
Prepayment for equipment 12,314 36,911
Net defined benefit - non-current 4,6(9) 8,741 6,733
Other non-current assets 4 11,357 14,289
Total non-current assets 1,568,805 1,731,067

Total Assets
$3,081,376 $3,416,739

(continued)


English Translation of Parent Company Only Financial Statements Originally Issued in Chinese
SUNKO INK CO., LTD.
PARENT COMPANY ONLY BALANCE SHEETS (Continued)
31 December 2025 and 2024
(Expressed in Thousands of New Taiwan Dollars)

Liabilities and Equity Notes As of 31 December
2025 2024
Current liabilities
Short-term loans 4,6(6) $251,181 $122,880
Financial liabilities at fair value through profit or loss - current 4,12(8) 145 402
Contract liabilities - current 4,6(11) 78,411 631
Notes payable 104 154
Accounts payable 156,131 213,329
Other payables 6(7) 154,905 151,341
Lease liabilities - current 4,6(13)&7 32,208 29,818
Current portion of long-term loans 4,6(8) 122,016 195,038
Other current liabilities 12,13 197 201
Total current liabilities 795,298 713,794
Non-current liabilities
Long-term loans 4,6(8) 515,996 630,616
Deferred tax liabilities 4,6(17) 72,514 73,129
Lease liabilities, non-current 4,6(13)&7 50,238 60,550
Total non-current liabilities 638,748 764,295
Total liabilities 1,434,046 1,478,089
Equity
Capital
Common stock 6(10) 1,848,841 1,848,841
Additional paid-in capital 6(10) 42,255 42,255
Retained earnings 6(10)
Legal reserve 35,199 86,893
Accumulated deficits to be offset (275,756) (51,694)
Subtotal (240,557) 35,199
Other equity (3,209) 12,355
Total equity 1,647,330 1,938,650
Total Liabilities and Equity $3,081,376 $3,416,739

(The accompanying notes are an integral part of the parent company only financial statements)


English Translation of Parent Company Only Financial Statements Originally Issued in Chinese
SUNKO INK CO., LTD.
PARENT COMPANY ONLY STATEMENTS OF COMPREHENSIVE INCOME
For the years ended 31 December 2025 and 2024
(Expressed in Thousands of New Taiwan Dollars, Except for Earnings per Share)

For the years ended 31 December
Notes 2025 2024
Operating revenues 4,6(11)&7 $1,774,757 $2,286,720
Operating costs 6(14) (1,904,370) (2,280,331)
Gross (loss) profit (129,613) 6,389
Operating expenses 6(14)
Selling and marketing expense (50,428) (54,330)
General and administrative expense (113,650) (89,373)
Research and development expense (42,323) (45,872)
Expected credit gains 6(12) 1,877 1,501
Total operating expenses (204,524) (188,074)
Operating loss (334,137) (181,685)
Non-operating income and expenses 6(15),7
Interest revenue 3,564 5,390
Other income 7,247 7,440
Other gains and losses (10,310) 11,135
Finance costs (20,702) (27,225)
Share of profit or loss of subsidiaries, associates and joint ventures 4 9 (940)
Total non-operating income and expenses (20,192) (4,200)
Loss from continuing operations before income tax (354,329) (185,885)
Income tax benefit 4,6(17) 14,690 3,309
Net loss (339,639) (182,576)
Other comprehensive (loss) income 6(16)
Items that will not be reclassified subsequently to profit or loss
Remeasurements of defined benefit pension plans (1,261) 2,167
Unrealized gains or losses from equity instruments investments
measured at fair value through other comprehensive income 49,328 11,797
Income tax relating to items that will not be reclassified subsequently 252 (433)
Total other comprehensive income , net of tax 48,319 13,531
Total comprehensive (loss) income $(291,320) $(169,045)
Loss per share (NT$) 4,6(18)
Loss per share-basic $(1.84) $(0.98)
Loss per share-diluted $(1.84) $(0.98)

(The accompanying notes are an integral part of the parent company only financial statements)

9


English Translation of Parent Company Only Financial Statements Originally Issued in Chinese

SUNKO INK CO., LTD.

PARENT COMPANY ONLY STATEMENTS OF CHANGES IN EQUITY

For the years ended 31 December 2025 and 2024

(Expressed in Thousands of New Taiwan Dollars)

Total Equity
Common Stock Additional Paid-in Capital Retained Earnings Other Components of Equity Total Equity
Legal Reserve Special reserve Accumulated Deficits to be Offset Unrealized Gain or Loss on Financial Assets Measured at Fair Value through other Comprehensive Income
Balance as of 1 January 2024 6(10) $1,848,841 $42,255 $86,893 $3,366 $125,782 $558 $2,107,695
Appropriation and distribution of 2023 retained earnings
Reversal of special reserve (3,366) 3,366 -
Net loss for the year ended 31 December 2024 (182,576) (182,576)
Other comprehensive income (loss), net of tax for the year ended 31 December 2024 6(16) 1,734 11,797 13,531
Total comprehensive income (loss) - - - - (180,842) 11,797 (169,045)
Balance as of 31 December 2024 $1,848,841 $42,255 $86,893 $- $(51,694) $12,355 $1,938,650
Balance as of 1 January 2025 6(10) $1,848,841 $42,255 $86,893 $- $(51,694) $12,355 $1,938,650
Appropriation and distribution of 2024 retained earnings
Legal reserve used to offset accumulated deficits 6(10) (51,694) 51,694 -
Net loss for the year ended 31 December 2025 (339,639) (339,639)
Other comprehensive income (loss), net of tax for the year ended 31 December 2025 6(16) (1,009) 49,328 48,319
Total comprehensive income (loss) - - - - (340,648) 49,328 (291,320)
Disposal of equity instruments measured at fair value through other comprehensive income 64,892 (64,892) -
Balance as of 31 December 2025 $1,848,841 $42,255 $35,199 $- $(275,756) $(3,209) $1,647,330

(The accompanying notes are an integral part of the parent company only financial statements)

10


English Translation of Parent Company Only Financial Statements Originally Issued in Chinese

SUNKO INK CO., LTD.

PARENT COMPANY ONLY STATEMENTS OF CASH FLOWS

For the years ended 31 December 2025 and 2024

(Expressed in Thousands of New Taiwan Dollars)

For the years ended 31 December For the years ended 31 December
2025 2024 2025 2024
Cash flows from operating activities: Cash flows from investing activities:
Net loss before tax $(354,329) $(185,885) Proceeds from disposal of financial assets measured at fair value through other comprehensive income 112,840 -
Adjustments to reconcile net loss before tax to net cash provided by operating activities: Acquisition of financial assets measured at amortized cost (183,744) -
Depreciation expense (including amounts recorded in other gains and losses) 226,159 238,747 Proceeds from disposal of financial assets measured at amortized cost 67,934 -
Amortisation expense (including amounts recorded in other expenses) 11,638 8,999 Acquisition of financial assets measured at fair value through profit or loss (8,254) -
Expected credit gains (1,877) (1,501) Proceeds from disposal of financial assets measured at fair value through profit or loss 8,654 -
Net (gain) loss of financial assets/liabilities at fair value through profit or loss (527) 402 Acquisition of property, plant and equipment (62,786) (66,071)
Finance costs 20,702 27,225 Proceeds from disposal of financial assets measured at fair value through profit or loss 480 267
Interest revenue (3,564) (5,390) Acquisition of intangible assets (2,804) (2,020)
Dividend income (2,226) (2,778) Increase in other non-current assets (5,546) (4,477)
Share of profit or loss of subsidiaries, associates and joint ventures (9) 940 Increase in prepayment for equipment (26,839) (17,956)
Loss on disposal of property, plant and equipment 992 364 Net cash used in investing activities (100,065) (90,257)
Other (130) -
Changes in operating assets and liabilities: Cash flows from financing activities:
Decrease in notes receivable 601 17,352 Increase in short-term loans 643,638 681,716
Decrease in accounts receivable 139,832 51,890 Decrease in short-term loans (515,337) (721,748)
Increase in other receivables (746) (403) Increase in long-term loans 32,700 130,000
Decrease in inventories, net 175,010 102,939 Repayment of long-term loans (220,342) (212,928)
Decrease (increase) in prepayments 28,100 (20,633) Cash payments for the principle portion of the lease liabilities (34,920) (36,459)
Decrease (increase) in other current assets 485 (280) Net cash used in financing activities (94,261) (159,419)
Increase (decrease) in contract liabilities 77,780 (24,674) Net increase (decrease) in cash and cash equivalents 53,396 (49,684)
Decrease in notes payable (50) (72) Cash and cash equivalents at beginning of year 450,669 500,353
(Decrease) increase in accounts payable (57,198) 28,410 Cash and cash equivalents at end of year $504,065 $450,669
Increase (decrease) in other payables 1,580 (13,142)
Decrease in other current liabilities (4) (4)
Decrease in net defined benefit obligation - non-current (3,269) (2,918)
Cash generated from operations 258,950 219,588
Interest received 3,491 5,309
Dividends received 2,226 2,778
Interest paid (19,911) (27,683)
Income tax refunded 2,966 -
Net cash provided by operating activities 247,722 199,992

(The accompanying notes are an integral part of the parent company only financial statements)


SUNKO INK CO., LTD.

Notes to Parent Company Only Financial Statements

For the years Ended 31 December 2025 and 2024
(Expressed in Thousands of New Taiwan Dollars, unless Otherwise Stated)

  1. General

Sunko Ink Co., Ltd. (hereinafter “the Company”) was incorporated in December 1974. The Company is engaged in manufacturing and trading of certain chemicals or industrial materials. Major product lines are as follows:

a. Argochemicals
b. Fine Chemicals: curing agent, non-halogenated flame retardant, reducing agent, antioxidant
c. Polymer: PU Based surface treating agent, Polymer-TPU, Polymer-TPV
d. UV Absorbers

In May 1996, the Company’s shares were listed on the Taiwan Stock Exchange (TWSE), when the registered office was located at No. 139, Renmei Rd., Dali Dist., Taichung City 412036, Taiwan (R.O.C.). On 30 April 2020, as approved by Ministry of Economic Affairs, the Company’s registered operating office address was changed to 5F., No. 229, Zhongxing St., West Dist., Taichung City 403022, Taiwan (R.O.C.).

On 30 March 2016, the Company merged with Kuo Ching Chemical Co., Ltd. (hereinafter “Kuo Ching”). Kuo Ching was incorporated in April 1977, mainly engaged in production and trading of agrochemicals, fine chemicals, and other polymer materials. In October 2009, Kuo Ching’s shares were listed on the Emerging Stock Board. To improve efficiency and competitive capabilities, the Company merged with Kuo Ching on 30 March 2015 to integrate both entities’ production capacities, research resources, marketing and product lines. The Company was the surviving Company which acquired all of Kuo Ching’s assets, liabilities, rights or obligations.

  1. Date and procedures of authorization of financial statements for issue

The parent company only financial statements of the Company for the years ended 31 December 2025 and 2024 were approved to release in accordance with a resolution of the board of directors’ meeting on 6 March 2026.

12


  1. Newly issued or revised standards and interpretations

(1) Changes in accounting policies resulting from applying for the first-time certain standards and amendments

The Company applied for the first time International Financial Reporting Standards, International Accounting Standards, and Interpretations issued, revised or amended which are recognized by Financial Supervisory Commission ("FSC") and become effective for annual periods beginning on or after 1 January 2025. The adoption of these new standards and amendments had no material impact on the Company.

(2) Standards or interpretations issued, revised or amended, by International Accounting Standards Board ("IASB") which have been endorsed by FSC, and not yet adopted by the Company as at the date when the Company's financial statements were authorized for issue, are listed below.

Items New, Revised or Amended Standards and Interpretations Effective Date issued by IASB
a IFRS 17 “Insurance Contracts” 1 January 2023
b Amendments to the Classification and Measurement of Financial Instruments – Amendments to IFRS 9 and IFRS 7 1 January 2026
c Annual Improvements to IFRS Accounting Standards – Volume 11 1 January 2026
d Contracts Referencing Nature-dependent Electricity – Amendments to IFRS 9 and IFRS 7 1 January 2026

(a) IFRS 17 "Insurance Contracts"

IFRS 17 provides a comprehensive model for insurance contracts, covering all relevant accounting aspects (including recognition, measurement, presentation and disclosure requirements). The core of IFRS 17 is the General (building block) Model, under this model, on initial recognition, an entity shall measure a group of insurance contracts at the total of the fulfilment cash flows and the contractual service margin. The carrying amount of a group of insurance contracts at the end of each reporting period shall be the sum of the liability for remaining coverage and the liability for incurred claims.

Other than the General Model, the standard also provides a specific adaptation for contracts with direct participation features (the Variable Fee Approach) and a simplified approach (Premium Allocation Approach) mainly for short-duration contracts.


IFRS 17 was issued in May 2017 and it was amended in 2020 and 2021. The amendments include deferral of the date of initial application of IFRS 17 by two years to annual beginning on or after 1 January 2023 (from the original effective date of 1 January 2021); provide additional transition reliefs; simplify some requirements to reduce the costs of applying IFRS 17 and revise some requirements to make the results easier to explain. IFRS 17 replaces an interim Standard – IFRS 4 Insurance Contracts – from annual reporting periods beginning on or after 1 January 2023.

(b) Amendments to the Classification and Measurement of Financial Instruments – Amendments to IFRS 9 and IFRS 7

The amendments include:

(1) Clarify that a financial liability is derecognised on the settlement date and describe the accounting treatment for settlement of financial liabilities using an electronic payment system before the settlement date.
(2) Clarify how to assess the contractual cash flow characteristics of financial assets that include environmental, social and governance (ESG)-linked features and other similar contingent features.
(3) Clarify the treatment of non-recourse assets and contractually linked instruments.
(4) Require additional disclosures in IFRS 7 for financial assets and liabilities with contractual terms that reference a contingent event (including those that are ESG-linked), and equity instruments classified at fair value through other comprehensive income.

(c) Annual Improvements to IFRS Accounting Standards – Volume 11

(1) Amendments to IFRS 1
(2) Amendments to IFRS 7
(3) Amendments to Guidance on implementing IFRS 7
(4) Amendments to IFRS 9
(5) Amendments to IFRS 10
(6) Amendments to IAS 7

(d) Contracts Referencing Nature-dependent Electricity – Amendments to IFRS 9 and IFRS 7

The amendments include:

(1) Clarify the application of the ‘own-use’ requirements.
(2) Permit hedge accounting if these contracts are used as hedging instruments.
(3) Add new disclosure requirements to enable investors to understand the effect of these contracts on a company’s financial performance and cash flows.

The abovementioned standards and amendments are applicable for annual periods beginning on or after 1 January 2026 and have no material impact on the Company.

14


(3) Standards or interpretations issued, revised or amended, by IASB which have not been endorsed by FSC, and not yet adopted by the Company as at the date when the Company's financial statements were authorized for issue, are listed below.

Items New, Revised or Amended Standards and Interpretations Effective Date issued by IASB
a IFRS 10 “Consolidated Financial Statements” and IAS 28 “Investments in Associates and Joint Ventures” – Sale or Contribution of Assets between an Investor and its Associate or Joint Ventures To be determined by IASB
b IFRS 18 “Presentation and Disclosure in Financial Statements” 1 January 2027 (Note)
c Disclosure Initiative – Subsidiaries without Public Accountability: Disclosures (IFRS 19) 1 January 2027
d Translation to a Hyperinflationary Presentation Currency (Amendments to IAS 21 and IAS 29) 1 January 2027

Note: On 25 September 2025, the FSC announced in a press release that Taiwan will adopt IFRS 18 in 2028. In addition, entities in Taiwan with a need for early adoption may elect to early adopt IFRS 18 upon approval by the FSC.

(a) IFRS 10 “Consolidated Financial Statements” and IAS 28 “Investments in Associates and Joint Ventures” - Sale or Contribution of Assets between an Investor and its Associate or Joint Ventures

The amendments address the inconsistency between the requirements in IFRS 10 Consolidated Financial Statements and IAS 28 Investments in Associates and Joint Ventures, in dealing with the loss of control of a subsidiary that is contributed to an associate or a joint venture. IAS 28 restricts gains and loss arising from contributions of non-monetary assets to an associate or a joint venture to the extent of the interest attributable to the other equity holders in the associate or joint ventures. IFRS 10 requires full profit or loss recognition on the loss of control of the subsidiary. IAS 28 was amended so that the gain or loss resulting from the sale or contribution of assets that constitute a business as defined in IFRS 3 between an investor and its associate or joint venture is recognized in full.

IFRS 10 was also amended so that the gains or loss resulting from the sale or contribution of a subsidiary that does not constitute a business as defined in IFRS 3 between an investor and its associate or joint venture is recognized only to the extent of the unrelated investors' interests in the associate or joint venture.


(b) IFRS 18 “Presentation and Disclosure in Financial Statements”

IFRS 18 replaces IAS 1 Presentation of Financial Statements. The main changes are as below:

(1) Improved comparability in the statement of profit or loss (income statement)
IFRS 18 requires entities to classify all income and expenses within their statement of profit or loss into one of five categories: operating; investing; financing; income taxes; and discontinued operations. The first three categories are new, to improve the structure of the income statement, and requires all entities to provide new defined subtotals, including operating profit or loss. The improved structure and new subtotals will give investors a consistent starting point for analyzing entities’ performance and make it easier to compare entities.

(2) Enhanced transparency of management-defined performance measures
IFRS 18 requires entities to disclose explanations of those entity-specific measures that are related to the income statement, referred to as management-defined performance measures.

(3) Useful grouping of information in the financial statements
IFRS 18 sets out enhanced guidance on how to organize information and whether to provide it in the primary financial statements or in the notes. The changes are expected to provide more detailed and useful information. IFRS 18 also requires entities to provide more transparency about operating expenses, helping investors to find and understand the information they need.

(c) Disclosure Initiative - Subsidiaries without Public Accountability: Disclosures (IFRS 19)

This new standard and its amendment permits subsidiaries without public accountability to provide reduced disclosures when applying IFRS Accounting Standards in their financial statements. IFRS 19 is optional for subsidiaries that are eligible and sets out the disclosure requirements for subsidiaries that elect to apply it.

(d) Translation to a Hyperinflationary Presentation Currency (Amendments to IAS 21 and IAS 29)

The amendments include:

(1) Clarify that when the entity’s functional currency is that of a non hyperinflationary economy but its presentation currency is the currency of a hyperinflationary economy, the entity shall translate its results and financial position using the closing rate at the date of the most recent statement of financial position.

16


(2) In the above circumstances, when the presentation currency ceases to be hyperinflationary economy, the entity shall not retranslate amounts that arose before the beginning of the reporting period.

(3) When the entity’s functional currency and presentation currency are the currency of a hyperinflationary economy, the entity shall apply the relevant accounting treatment in accordance with paragraph 34 of IAS 29.

The abovementioned standards and interpretations issued by IASB have not yet endorsed by FSC at the date when the Company’s financial statements were authorized for issue, the local effective dates are to be determined by FSC. As the Company is still currently determining the potential impact of the new or amended standards and interpretations listed under (b), it is not practicable to estimate their impact on the Company at this point in time. The remaining new or amended standards and interpretations have no material impact on the Company.

  1. Summary of material accounting policies

(1) Statement of compliance

The parent company only financial statements of the Company for the years ended 31 December 2025 and 2024 have been prepared in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers (“the Regulations”).

(2) Basis of preparation

The Company prepared the parent company only financial statements in accordance with the Regulations. According to the Article 21 of the Regulation, which provided that the profit or loss and other comprehensive income for the period presented in the parent company only financial statements shall be the same as the profit or loss and other comprehensive income attributable to stockholders of the parent presented in the consolidated financial statements for the period, and the total equity presented in the parent company only financial statements shall be the same as the equity attributable to the parent company presented in the consolidated financial statements. Therefore, the Company accounted for its investments in subsidiaries using equity method and, accordingly, made necessary adjustments.

The parent company only financial statements have been prepared on a historical cost basis, except for financial instruments that have been measured at fair value. The parent company only financial statements are expressed in thousands of New Taiwan Dollars (NT$) unless otherwise stated.

17


(3) Foreign currency transactions

The Company’s parent company only financial statements are presented in its functional currency, New Taiwan Dollars (NT$). Items included in the financial statements are measured using that functional currency.

Transactions in foreign currencies are initially recorded by the Company at the respective functional currency rates prevailing at the date of transaction. Monetary assets and liabilities denominated in foreign currencies are translated at the functional currency closing rates of exchange at the reporting date. Non-monetary items measured at fair value in foreign currencies are translated using the exchange rates at the date when the fair value is determined. Non-monetary items that are measured at historical cost in foreign currencies are translated using the exchange rates as at the dates of the initial transactions.

All exchange differences arising on the settlement of monetary items or on translating monetary items are taken to profit or loss in the period in which they arise except for the following:

(a) Exchange differences arising from foreign currency borrowings for an acquisition of a qualifying asset to the extent that they are regarded as an adjustment to interest costs are included in the borrowing costs that are eligible for capitalization.

(b) Foreign currency items within the scope of IFRS 9 Financial Instruments are accounted for based on the accounting policy for financial instruments.

(c) Exchange differences arising on a monetary item that forms part of a reporting entity’s net investment in a foreign operation is recognized initially in other comprehensive income and reclassified from equity to profit or loss on disposal of the net investment.

When a gain or loss on a non-monetary item is recognized in other comprehensive income, any exchange component of that gain or loss is recognized in other comprehensive income. When a gain or loss on a non-monetary item is recognized in profit or loss, any exchange component of that gain or loss is recognized in profit or loss.

(4) Translation of foreign currency financial statements

The assets and liabilities of foreign operations are translated into NT$ at the closing rate of exchange prevailing at the reporting date and their income and expenses are translated at an average rate for the period. The exchange differences arising on the translation are recognized in other comprehensive income. On the disposal of a foreign operation, the cumulative amount of the exchange differences relating to that foreign operation, recognized in other comprehensive income and accumulated in the separate component of equity, is reclassified from equity to profit or loss when the gain or loss on disposal is recognized.

18


On the partial disposal of a subsidiary that includes a foreign operation that does not result in a loss of control, the proportionate share of the cumulative amount of the exchange differences recognized in other comprehensive income is re-attributed to the non-controlling interests in that foreign operation. In partial disposal of an associate or joint arrangement that includes a foreign operation that does not result in a loss of significant influence or joint control, only the proportionate share of the cumulative amount of the exchange differences recognized in other comprehensive income is reclassified to profit or loss.

Any goodwill and any fair value adjustments to the carrying amounts of assets and liabilities arising on the acquisition of a foreign operation are treated as assets and liabilities of the foreign operation and expressed in its functional currency.

(5) Current and non-current distinction

An asset is classified as current when:

(a) The Company expects to realize the asset, or intends to sell or consume it, in its normal operating cycle;
(b) The Company holds the asset primarily for the purpose of trading;
(c) The Company expects to realize the asset within twelve months after the reporting period;
(d) The asset is cash or a cash equivalent unless the asset is restricted from being exchanged or used to settle a liability for at least twelve months after the reporting period.

All other assets are classified as non-current.

A liability is classified as a current when:

(a) The Company expects to settle the liability in normal operating cycle;
(b) The Company holds the liability primarily for the purpose of trading;
(c) The liability is due to be settled within twelve months after the reporting period;
(d) The Company does not have the right at the end of the reporting period to defer settlement of the liability for at least twelve months after the reporting period.

All other liabilities are classified as non-current.

(6) Cash and cash equivalent

Cash and cash equivalents comprise cash on hand, demand deposits and short-term, highly liquid time deposits or investments that are readily convertible to known amounts of cash and which are subject to an insignificant risk of changes in value.

19


(7) Financial Instruments

Financial assets and financial liabilities are recognized when the Company becomes a party to the contractual provisions of the instrument.

Financial assets and financial liabilities within the scope of IFRS 9 Financial Instruments are recognized initially at fair value plus or minus, in the case of a financial asset or financial liability not at fair value through profit or loss, transaction costs that are directly attributable to the acquisition or issue of the financial assets or financial liabilities.

A. Financial instruments: Recognition and Measurement

The Company accounts for regular way purchase or sales of financial assets on the trade date.

The Company classified financial assets as subsequently measured at amortized cost, fair value through other comprehensive income or fair value through profit or loss considering both factors below:

(a) the Company’s business model for managing the financial assets and
(b) the contractual cash flow characteristics of the financial asset.

Financial assets measured at amortized cost

A financial asset is measured at amortized cost if both of the following conditions are met and presented as note receivables, trade receivables financial assets measured at amortized cost and other receivables etc., on balance sheet as at the reporting date:

(a) the financial asset is held within a business model whose objective is to hold financial assets in order to collect contractual cash flows and
(b) the contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.

Such financial assets are subsequently measured at amortized cost (the amount at which the financial asset is measured at initial recognition minus the principal repayments, plus or minus the cumulative amortization using the effective interest method of any difference between the initial amount and the maturity amount and adjusted for any loss allowance) and is not part of a hedging relationship. A gain or loss is recognized in profit or loss when the financial asset is derecognized, through the amortization process or in order to recognize the impairment gains or loss.

20


Interest revenue is calculated by using the effective interest method. This is calculated by applying the effective interest rate to the gross carrying amount of a financial asset except for:

(a) purchased or originated credit-impaired financial assets. For those financial assets, the Company applies the credit-adjusted effective interest rate to the amortized cost of the financial asset from initial recognition.

(b) financial assets that are not purchased or originated credit-impaired financial assets but subsequently have become credit-impaired financial assets. For those financial assets, the Company applies the effective interest rate to the amortized cost of the financial asset in subsequent reporting periods.

Financial asset measured at fair value through other comprehensive income

A financial asset is measured at fair value through other comprehensive income if both of the following conditions are met:

(a) the financial asset is held within a business model whose objective is achieved by both collecting contractual cash flows and selling financial assets and

(b) the contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.

Recognition of gain or loss on a financial asset measured at fair value through other comprehensive income are described as below:

(a) A gain or loss on a financial asset measured at fair value through other comprehensive income recognized in other comprehensive income, except for impairment gains or loss and foreign exchange gains and loss, until the financial asset is derecognized or reclassified.

(b) When the financial asset is derecognized the cumulative gain or loss previously recognized in other comprehensive income is reclassified from equity to profit or loss as a reclassification adjustment.

(c) Interest revenue is calculated by using the effective interest method. This is calculated by applying the effective interest rate to the gross carrying amount of a financial asset except for:

(i) Purchased or originated credit-impaired financial assets. For those financial assets, the Company applies the credit-adjusted effective interest rate to the amortized cost of the financial asset from initial recognition.

(ii) Financial assets that are not purchased or originated credit-impaired financial assets but subsequently have become credit-impaired financial assets. For those financial assets, the Company applies the effective interest rate to the amortized cost of the financial asset in subsequent reporting periods.

21


Besides, for certain equity investments within the scope of IFRS 9 that is neither held for trading nor contingent consideration recognized by an acquirer in a business combination to which IFRS 3 applies, the Company made an irrevocable election to present the changes of the fair value in other comprehensive income at initial recognition. Amounts presented in other comprehensive income shall not be subsequently transferred to profit or loss (when disposal of such equity instrument, its cumulated amount included in other components of equity is transferred directly to the retained earnings) and these investments should be presented as financial assets measured at fair value through other comprehensive income on the balance sheet. Dividends on such investment are recognized in profit or loss unless the dividends clearly represents a recovery of part of the cost of investment.

Financial asset measured at fair value through profit or loss

Financial assets were classified as measured at amortized cost or measured at fair value through other comprehensive income based on aforementioned criteria. All other financial assets were measured at fair value through profit or loss and presented on the balance sheet as financial assets measured at fair value through profit or loss.

Such financial assets are measured at fair value, the gains or loss resulting from remeasurement is recognized in profit or loss which includes any dividend or interest received on such financial assets.

B. Impairment of financial assets

The Company recognizes a loss allowance for expected credit loss on debt instrument investments measured at fair value through other comprehensive income and financial asset measured at amortized cost. The loss allowance on debt instrument investments measured at fair value through other comprehensive income is recognized in other comprehensive income and not reduce the carrying amount in the balance sheet.

The Company measures expected credit loss of a financial instrument in a way that reflects:

(a) an unbiased and probability-weighted amount that is determined by evaluating a range of possible outcomes
(b) the time value of money
(c) reasonable and supportable information that is available without undue cost or effort at the reporting date about past events, current conditions and forecasts of future economic conditions

22


The loss allowance is measured as follows:

(a) At an amount equal to 12-month expected credit loss: the credit risk on a financial asset has not increased significantly since initial recognition or the financial asset is determined to have low credit risk at the reporting date. In addition, the Company measures the loss allowance at an amount equal to lifetime expected credit loss in the previous reporting period, but determines at the current reporting date that the credit risk on a financial asset has increased significantly since initial recognition is no longer met.

(b) At an amount equal to the lifetime expected credit loss: the credit risk on a financial asset has increased significantly since initial recognition or financial asset that is purchased or originated credit-impaired financial asset.

(c) For trade receivables or contract assets arising from transactions within the scope of IFRS 15, the Company measures the loss allowance at an amount equal to lifetime expected credit loss.

(d) For lease receivables arising from transactions within the scope of IFRS 16, the Company measures the loss allowance at an amount equal to lifetime expected credit loss.

At each reporting date, the Company needs to assess whether the credit risk on a financial asset has increased significantly since initial recognition by comparing the risk of a default occurring at the reporting date and the risk of default occurring at initial recognition. Please refer to Note 12 for further details on credit risk.

C. Derecognition of financial assets

A financial asset is derecognized when:

(a) The rights to receive cash flows from the asset have expired.

(b) The Company has transferred the asset and substantially all the risks and rewards of the asset have been transferred.

(c) The Company has neither transferred nor retained substantially all the risks and rewards of the asset, but has transferred control of the asset.

On derecognition of a financial asset in its entirety, the difference between the carrying amount and the consideration received or receivable including any cumulative gain or loss that had been recognized in other comprehensive income, is recognized in profit or loss.

23


D. Financial liabilities and equity

Classification between liabilities or equity

The Company classifies the instrument issued as a financial liability or an equity instrument in accordance with the substance of the contractual arrangement and the definitions of a financial liability, and an equity instrument.

Equity instruments

An equity instrument is any contract that evidences a residual interest in the assets of an entity after deducting all of its liabilities. The transaction costs of an equity transaction are accounted for as a deduction from equity (net of any related income tax benefit) to the extent they are incremental costs directly attributable to the equity transaction that otherwise would have been avoided.

Compound instruments

The Company evaluates the terms of the convertible bonds issued to determine whether it contains both a liability and an equity component. Furthermore, the Company assesses if the economic characteristics and risks of the put and call options contained in the convertible bonds are closely related to the economic characteristics and risk of the host contract before separating the equity element.

For the liability component excluding the derivatives, its fair value is determined based on the rate of interest applied at that time by the market to instruments of comparable credit status. The liability component is classified as a financial liability measured at amortized cost before the instrument is converted or settled.

For the embedded derivative that is not closely related to the host contract (for example, if the exercise price of the embedded call or put option is not approximately equal on each exercise date to the amortized cost of the host debt instrument), it is classified as a liability component and subsequently measured at fair value through profit or loss unless it qualifies for an equity component. The equity component is assigned the residual amount after deducting from the fair value of the instrument as a whole the amount separately determined for the liability component. Its carrying amount is not remeasured in the subsequent accounting periods. If the convertible bond issued does not have an equity component, it is accounted for as a hybrid instrument in accordance with the requirements under IFRS 9 Financial Instruments.

24


Transaction costs are apportioned between the liability and equity components of the convertible bond based on the allocation of proceeds to the liability and equity components when the instruments are initially recognized.

On conversion of a convertible bond before maturity, the carrying amount of the liability component being the amortized cost at the date of conversion is transferred to equity.

Financial liabilities

Financial liabilities within the scope of IFRS 9 Financial Instruments are classified as financial liabilities at fair value through profit or loss or financial liabilities measured at amortized cost upon initial recognition.

Financial liabilities at fair value through profit or loss

Financial liabilities at fair value through profit or loss include financial liabilities held for trading and financial liabilities designated as at fair value through profit or loss.

A financial liability is classified as held for trading if:

(a) it is acquired or incurred principally for the purpose of selling or repurchasing it in the near term;

(b) on initial recognition it is part of a portfolio of identified financial instruments that are managed together and for which there is evidence of a recent actual pattern of short-term profit-taking;

(c) it is a derivative (except for a derivative that is a financial guarantee contract or a designated and effective hedging instrument).

If a contract contains one or more embedded derivatives, the entire hybrid (combined) contract may be designated as a financial liability at fair value through profit or loss; or a financial liability may be designated as at fair value through profit or loss when doing so results in more relevant information, because either:

(a) it eliminates or significantly reduces a measurement or recognition inconsistency; or

(b) a group of financial liabilities or financial assets and financial liabilities is managed and its performance is evaluated on a fair value basis, in accordance with a documented risk management or investment strategy, and information about the Company is provided internally on that basis to the key management personnel.

Gains or loss on the subsequent measurement of liabilities at fair value through profit or loss including interest paid are recognized in profit or loss.

25


26

Financial liabilities at amortized cost

Financial liabilities measured at amortized cost include interest bearing loans and borrowings that are subsequently measured using the effective interest rate method after initial recognition. Gains and loss are recognized in profit or loss when the liabilities are derecognized as well as through the effective interest rate method amortization process.

Amortized cost is calculated by taking into account any discount or premium on acquisition and fees or transaction costs.

Derecognition of financial liabilities

A financial liability is derecognized when the obligation under the liability is discharged or cancelled or expires.

When an existing financial liability is replaced by another from the same lender on substantially different terms, or the terms of an existing liability are substantially modified (whether or not attributable to the financial difficulty of the debtor), such an exchange or modification is treated as a derecognition of the original liability and the recognition of a new liability, and the difference in the respective carrying amounts and the consideration paid, including any non-cash assets transferred or liabilities assumed, is recognized in profit or loss.

E. Offsetting of financial instruments

Financial assets and financial liabilities are offset and the net amount reported in the balance sheet if, and only if, there is a currently enforceable legal right to offset the recognized amounts and there is an intention to settle on a net basis, or to realize the assets and settle the liabilities simultaneously.

(8) Derivative instruments

The Company uses derivative instruments to hedge its foreign currency risks and interest rate risks. A derivative is classified in the balance sheet as assets or liabilities at fair value through profit or loss except for derivatives that are designated effective hedging instruments which are classified as derivative financial assets or liabilities for hedging.


Derivative instruments are initially recognized at fair value on the date on which a derivative contract is entered into and are subsequently remeasured at fair value. Derivatives are carried as financial assets when the fair value is positive and as financial liabilities when the fair value is negative. The changes in fair value of derivatives are taken directly to profit or loss, except for the effective portion of hedges, which is recognized in either profit or loss or equity according to types of hedges used.

When the host contracts are either non-financial assets or liabilities, derivatives embedded in host contracts are accounted for as separate derivatives and recorded at fair value if their economic characteristics and risks are not closely related to those of the host contracts and the host contracts are not designated at fair value though profit or loss.

(9) Fair value measurement

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The fair value measurement is based on the presumption that the transaction to sell the asset or transfer the liability takes place either:

A. In the principal market for the asset or liability, or
B. In the absence of a principal market, in the most advantageous market for the asset or liability

The principal or the most advantageous market must be accessible to by the Company.

The fair value of an asset or a liability is measured using the assumptions that market participants would use when pricing the asset or liability, assuming that market participants in their economic best interest.

A fair value measurement of a non-financial asset takes into account a market participant's ability to generate economic benefits by using the asset in its highest and best use or by selling it to another market participant that would use the asset in its highest and best use.

The Company uses valuation techniques that are appropriate in the circumstances and for which sufficient data are available to measure fair value, maximizing the use of relevant observable inputs and minimizing the use of unobservable inputs.

27


(10) Inventories

Inventories are valued at lower of cost and net realizable value item by item.

Costs incurred in bringing each inventory to its present location and condition are accounted for as follows:

Raw materials - Purchase cost under weighted average cost method.

Finished goods and work in progress - Cost of direct materials and direct labor and manufacturing overheads but excluding borrowing costs.

Net realizable value is the estimated selling price in the ordinary course of business, less estimated costs of completion and the estimated costs necessary to make the sale.

Rendering of services is accounted in accordance with IFRS 15 and not within the scope of inventories.

(11) Investments accounted for under the equity method

According to Article 21 of the Regulation, the Company's investment in subsidiaries was presented as "Investments accounted for using equity method" and made necessary adjustments. The profit or loss during the period and other comprehensive income presented in the parent Company only financial statements shall be the same as the allocations of profit or loss during the period and of other comprehensive income attributable to shareholders of the parent presented in the financial statements prepared on a consolidated basis, and the shareholders' equity presented in the parent Company only financial statements shall be the same as the equity attributable to shareholders of the parent presented in the financial statements prepared on a consolidated basis. The adjustment was considered the difference between investment in subsidiaries in consolidated financial statements according to IFRS 10 "Consolidated financial statements" and application of IFRS to different reporting entities, debit/credit "Investment accounted for using equity method", "Share of profit or loss of subsidiaries, associates and joint ventures" or "Share of other comprehensive profit or loss of subsidiaries, associates and joint ventures" etc.

The Company's investment in its associate is accounted for using the equity method other than those that meet the criteria to be classified as held for sale. An associate is an entity over which the Company has significant influence.

28


Under the equity method, the investment in the associate is carried in the balance sheet at cost and adjusted thereafter for the post-acquisition change in the Company’s share of net assets of the associate. After the interest in the associate is reduced to zero, additional loss are provided for, and a liability is recognized, only to the extent that the Company has incurred legal or constructive obligations or made payments on behalf of the associate. Unrealized gains and loss resulting from transactions between the Company and the associate are eliminated to the extent of the Company’s related interest in the associate.

When changes in the net assets of an associate occur and not those that are recognized in profit or loss or other comprehensive income and do not affect the Company’s percentage of ownership interests in the associate, the Company recognizes such changes in equity based on its percentage of ownership interests. The resulting capital surplus recognized will be reclassified to profit or loss at the time of disposing the associate on a pro-rata basis.

When the associate issues new stock, and the Company’s interest in an associate is reduced or increased as the Company fails to acquire shares newly issued in the associate proportionately to its original ownership interest, the increase or decrease in the interest in the associate is recognized in additional paid-in capital and investment accounted for using the equity method. When the interest in the associate is reduced, the cumulative amounts previously recognized in other comprehensive income are reclassified to profit or loss or other appropriate items. The aforementioned capital surplus recognized is reclassified to profit or loss on a pro rata basis when the Company disposes the associate.

The financial statements of the associate are prepared for the same reporting period as the Company. Where necessary, adjustments are made to bring the accounting policies in line with those of the Company.

The Company determines at each reporting date whether there is any objective evidence that the investment in the associate is impaired in accordance with IAS 28 Investments in Associates. If this is the case the Company calculates the amount of impairment as the difference between the recoverable amount of the associate and its carrying value and recognizes the amount in the ‘share of profit or loss of an associate’ in the statement of comprehensive income in accordance with IAS 36 Impairment of Assets. In determining the value in use of the investment, the Company estimates:

(a) Its share of the present value of the estimated future cash flows expected to be generated by the associate, including the cash flows from the operations of the associate and the proceeds on the ultimate disposal of the investment; or
(b) The present value of the estimated future cash flows expected to arise from dividends to be received from the investment and from its ultimate disposal.

29


Because goodwill that forms part of the carrying amount of an investment in an associate is not separately recognized, it is not tested for impairment separately by applying the requirements for impairment testing goodwill in IAS 36 Impairment of Assets.

Upon loss of significant influence over the associate, the Company measures and recognizes any retaining investment at its fair value. Any difference between the carrying amount of the associate upon loss of significant influence and the fair value of the retaining investment and proceeds from disposal is recognized in profit or loss.

(12) Property, plant and equipment

Property, plant and equipment is stated at cost, net of accumulated depreciation and accumulated impairment loss, if any. Such cost includes the cost of dismantling and removing the item and restoring the site on which it is located and borrowing costs for construction in progress if the recognition criteria are met. Each part of an item of property, plant and equipment with a cost that is significant in relation to the total cost of the item is depreciated separately. When significant parts of property, plant and equipment are required to be replaced in intervals, the Company recognized such parts as individual assets with specific useful lives and depreciation, respectively. The carrying amount of those parts that are replaced is derecognized in accordance with the derecognition provisions of IAS 16 Property, plant and equipment. When a major inspection is performed, its cost is recognized in the carrying amount of the plant and equipment as a replacement if the recognition criteria are satisfied. All other repair and maintenance costs are recognized in profit or loss as incurred.

Depreciation is calculated on a straight-line basis over the estimated economic lives of the following assets:

Items Estimated economic lives
Land improvements 5~20 years
Buildings 2~60 years
Machinery and equipment 1~25 years
Transportation equipment 3~10 years
Other equipment 1~20 years

An item of property, plant and equipment and any significant part initially recognized is derecognized upon disposal or when no future economic benefits are expected from its use or disposal. Any gain or loss arising on derecognition of the asset is recognized in non-operating income and expense.

30


The assets' residual values, useful lives and methods of depreciation are reviewed at each financial year end and adjusted prospectively, if appropriate, and are treated as changes in accounting estimates.

(13) Leases

The Company assesses whether the contract is, or contains, a lease. A contract is, or contains, a lease if the contract conveys the right to control the use of an identified asset for a period of time in exchange for consideration. To assess whether a contract conveys the right to control the use of an identified asset for a period of time, the Company assesses whether, throughout the period of use, has both of the following:

(a) the right to obtain substantially all of the economic benefits from use of the identified asset; and
(b) the right to direct the use of the identified asset.

For a contract that is, or contains, a lease, the Company accounts for each lease component within the contract as a lease separately from non-lease components of the contract. For a contract that contains a lease component and one or more additional lease or non-lease components, the Company allocates the consideration in the contract to each lease component on the basis of the relative stand-alone price of the lease component and the aggregate stand-alone price of the non-lease components. The relative stand-alone price of lease and non-lease components shall be determined on the basis of the price the lessor, or a similar supplier, would charge the Company for that component, or a similar component, separately. If an observable stand-alone price is not readily available, the Company estimates the stand-alone price, maximising the use of observable information.

Company as a lessee

Except for leases that meet and elect short-term leases or leases of low-value assets, the Company recognizes right-of-use asset and lease liability for all leases which the Company is the lessee of those lease contracts.

At the commencement date, the Company measures the lease liability at the present value of the lease payments that are not paid at that date. The lease payments are discounted using the interest rate implicit in the lease, if that rate can be readily determined. If that rate cannot be readily determined, the Company uses its incremental borrowing rate. At the commencement date, the lease payments included in the measurement of the lease liability comprise the following payments for the right to use the underlying asset during the lease term that are not paid at the commencement date:

31


(a) fixed payments (including in-substance fixed payments), less any lease incentives receivable;
(b) variable lease payments that depend on an index or a rate, initially measured using the index or rate as at the commencement date;
(c) amounts expected to be payable by the lessee under residual value guarantees;
(d) the exercise price of a purchase option if the Company is reasonably certain to exercise that option; and
(e) payments of penalties for terminating the lease, if the lease term reflects the lessee exercising an option to terminate the lease.

After the commencement date, the Company measures the lease liability on an amortised cost basis, which increases the carrying amount to reflect interest on the lease liability by using an effective interest method; and reduces the carrying amount to reflect the lease payments made.

At the commencement date, the Company measures the right-of-use asset at cost. The cost of the right-of-use asset comprises:

(a) the amount of the initial measurement of the lease liability;
(b) any lease payments made at or before the commencement date, less any lease incentives received;
(c) any initial direct costs incurred by the lessee; and
(d) an estimate of costs to be incurred by the lessee in dismantling and removing the underlying asset, restoring the site on which it is located or restoring the underlying asset to the condition required by the terms and conditions of the lease.

For subsequent measurement of the right-of-use asset, the Company measures the right-of-use asset at cost less any accumulated depreciation and any accumulated impairment loss. That is, the Company measures the right-of-use applying a cost model.

If the lease transfers ownership of the underlying asset to the Company by the end of the lease term or if the cost of the right-of-use asset reflects that the Company will exercise a purchase option, the Company depreciates the right-of-use asset from the commencement date to the end of the useful life of the underlying asset. Otherwise, the Company depreciates the right-of-use asset from the commencement date to the earlier of the end of the useful life of the right-of-use asset or the end of the lease term.

The Company applies IAS 36 Impairment of Assets to determine whether the right-of-use asset is impaired and to account for any impairment loss identified.

32


Except for those leases that the Company accounted for as short-term leases or leases of low-value assets, the Company presents right-of-use assets and lease liabilities in the balance sheet and separately presents lease-related interest expense and depreciation charge in the statement comprehensive income.

For short-term leases or leases of low-value assets, the Company elects to recognize the lease payments associated with those leases as an expense on either a straight-line basis over the lease term or another systematic basis.

Company as a lessor

At inception of a contract, the Company classifies each of its leases as either an operating lease or a finance lease. A lease is classified as a finance lease if it transfers substantially all the risks and rewards incidental to ownership of an underlying asset. A lease is classified as an operating lease if it does not transfer substantially all the risks and rewards incidental to ownership of an underlying asset. At the commencement date, the Company recognizes assets held under a finance lease in its balance sheet and present them as a receivable at an amount equal to the net investment in the lease.

For a contract that contains lease components and non-lease components, the Company allocates the consideration in the contract applying IFRS 15.

The Company recognizes lease payments from operating leases as rental income on either a straight-line basis or another systematic basis. Variable lease payments for operating leases that do not depend on an index or a rate are recognized as rental income when incurred.

(14) Intangible assets

Intangible assets acquired separately are measured on initial recognition at cost. The cost of intangible assets acquired in a business combination is its fair value as at the date of acquisition. Following initial recognition, intangible assets are carried at cost less any accumulated amortization and accumulated impairment loss, if any. Internally generated intangible assets which fail to meet the recognition criteria are not capitalized and the expenditures are reflected in profit or loss in the period incurred.

The useful lives of intangible assets are assessed as either finite or indefinite.

Intangible assets with finite lives are amortized over the useful economic life and assessed for impairment whenever there is an indication that the intangible assets may be impaired. The amortization period and the amortization method for an intangible asset with a finite useful life are reviewed at least at the end of each fiscal year. Changes in the expected useful life or the expected pattern of consumption of future economic benefits embodied in the asset is accounted for by changing the amortization period or method, as appropriate, and is treated as changes in accounting estimates.

33


Intangible assets with indefinite useful lives are not amortized, but are tested for impairment annually, either individually or at the cash-generating unit level. The assessment of indefinite life is reviewed annually to determine whether the indefinite life continues to be supportable. If not, the change in useful life from indefinite to finite is made on a prospective basis.

Gains or loss arising from derecognition of an intangible asset are measured as the difference between the net disposal proceeds and the carrying amount of the asset and are recognized in profit or loss when the asset is derecognized.

(15) Impairment of non-financial assets

The Company assesses at the end of each reporting period whether there is any indication that an asset in the scope of IAS 36 Impairment of Assets may be impaired. If any such indication exists, or when annual impairment testing for an asset is required, the Company estimates the asset’s recoverable amount. An asset’s recoverable amount is the higher of an asset’s or cash-generating unit’s (“CGU”) fair value less costs to sell and its value in use and is determined for an individual asset, unless the asset does not generate cash inflows that are largely independent of those from other assets or group of assets. Where the carrying amount of an asset or CGU exceeds its recoverable amount, the asset is considered impaired and is written down to its recoverable amount.

For assets excluding goodwill, an assessment is made at each reporting date as to whether there is any indication that previously recognized impairment loss may no longer exist or may have decreased. If such indication exists, the Company estimates the asset’s or cash-generating unit’s recoverable amount. A previously recognized impairment loss is reversed only if there has been an increase in the estimated service potential of an asset which in turn increases the recoverable amount. However, the reversal is limited so that the carrying amount of the asset does not exceed its recoverable amount, nor exceed the carrying amount that would have been determined, net of depreciation, had no impairment loss been recognized for the asset in prior years.

A cash generating unit, or group of cash-generating units, to which goodwill has been allocated is tested for impairment annually at the same time, irrespective of whether there is any indication of impairment. If an impairment loss is to be recognized, it is first allocated to reduce the carrying amount of any goodwill allocated to the cash generating unit (group of units), then to the other assets of the unit (group of units) pro rata on the basis of the carrying amount of each asset in the unit (group of units). Impairment loss relating to goodwill cannot be reversed in future periods for any reason.

An impairment loss of continuing operations or a reversal of such impairment loss is recognized in profit or loss.

34


(16) Post-employment benefits

All regular employees of the Company are entitled to a pension plan that is managed by an independently administered pension fund committee. Fund assets are deposited under the committee’s name in the specific bank account and hence, not associated with the Company and its domestic subsidiaries. Therefore, fund assets are not included in the Company’s parent Company only financial statements.

For the defined contribution plan, the Company and its domestic subsidiaries will make a monthly contribution of no less than 6% of the monthly wages of the employees subject to the plan. The Company recognizes expenses for the defined contribution plan in the period in which the contribution becomes due.

Post-employment benefit plan that is classified as a defined benefit plan uses the Projected Unit Credit Method to measure its obligations and costs based on actuarial assumptions. Re-measurements, comprising of the effect of the actuarial gains and loss, the effect of the asset ceiling (excluding net interest) and the return on plan assets, excluding net interest, are recognized as other comprehensive income with a corresponding debit or credit to retained earnings in the period in which they occur. Past service costs are recognized in profit or loss on the earlier of:

(a) the date of the plan amendment or curtailment, and
(b) the date that the Company recognizes restructuring-related costs

Net interest is calculated by applying the discount rate to the net defined benefit liability or asset, both as determined at the start of the annual reporting period, taking account of any changes in the net defined benefit liability (asset) during the period as a result of contribution and benefit payment.

(17) Provisions

Provisions are recognized when the Company has a present obligation (legal or constructive) as a result of a past event, it is probably that an outflow of resources embodying economic benefits will be required to settle the obligation and a reliable estimate can be made of the amount of the obligation. Where the Company expects some or all of a provision to be reimbursed, the reimbursement is recognized as a separate asset but only when the reimbursement is virtually certain. If the effect of the time value of money is material, provisions are discounted using a current pre-tax rate that reflects the risks specific to the liability. Where discounting is used, the increase in the provision due to the passage of time is recognized as a finance cost.

The liability to pay a levy is recognized progressively if the obligating event occurs over a period of time.

35


(18) Revenue recognition

The Company’s revenue arising from contracts with customers are primarily related to sale of goods and rendering services. The accounting policies are explained as follows:

Sale of goods

The Company manufactures and sells fitness equipment. Sales are recognized when control of the goods is transferred to the customer and the goods are delivered to the customers (the customer obtains the right and carrying value of the goods). The sales of goods transactions of the revenue are recognized based on the consideration stated in the contract. For certain sales of goods transactions, they are usually accompanied by volume discounts (based on the accumulated total sales amount for a specified period). Therefore, revenue from these sales is recognized based on the price specified in the contract, net of the estimated volume discounts.

The credit period of the Company’s sale of goods is from 30 to 150 days. For most of the contracts, when the Company transfers the goods to customers and has a right to an amount of consideration that is unconditional, these contracts are recognized as trade receivables. The Company usually collects the payments shortly after transfer of goods to customers; therefore, there is no significant financing component to the contract. For some of the contracts, the Company collects the payments when contracts signed-off and has the obligations to transfer the goods or provide the services, these contracts should be presented as contract liabilities.

The period between the transfers of contract liabilities to revenue is usually within one year, thus, no significant financing component has arisen.

(19) Borrowing cost

Borrowing costs directly attributable to the acquisition, construction or production of an asset that necessarily takes a substantial period of time to get ready for its intended use or sale are capitalized as part of the cost of the respective assets. All other borrowing costs are expensed in the period they occur. Borrowing costs consist of interest and other costs that an entity incurs in connection with the borrowing of funds.

(20) Income Tax

Income tax expense (income) is the aggregate amount included in the determination of profit or loss for the period in respect of current income tax and deferred income tax.

36


37

Current income tax

Current income tax assets and liabilities for the current period and prior periods are measured using the tax rates and tax laws that have been enacted or substantively enacted by the end of the reporting period. Current income tax relating to items recognized directly in other comprehensive income or equity is recognized in other comprehensive income or equity and not in profit or loss.

The income tax for undistributed earnings is recognized as income tax expense in the subsequent year when the distribution proposal is approved by the Shareholders’ meeting.

Deferred income tax

Deferred income tax is a temporary difference between the tax bases of assets and liabilities and their carrying amounts in financial statement at the reporting date.

Deferred tax liabilities are recognized for all taxable temporary differences, except:

A. The deferred tax liability arises from the initial recognition of goodwill or of an asset or liability in a transaction that is not a business combination; at the time of the transaction, affects neither the accounting profit nor taxable profit or loss; and at the time of the transaction, does not give rise to equal taxable and deductible temporary differences.

B. In respect of taxable temporary differences associated with investments in subsidiaries, associates and interests in joint arrangements, the timing of the reversal of the temporary differences can be controlled and it is probable that the temporary differences will not be reversed in the foreseeable future.

Deferred tax assets are recognized for all deductible temporary differences, carry forward of unused tax credits and any unused tax losses, to the extent that it is probable that taxable profit will be available against which the deductible temporary differences, and the carry forward of unused tax credits and unused tax loss can be utilized, except:

A. Where the deferred tax asset relating to the deductible temporary difference arises from the initial recognition of an asset or liability in a transaction that is not a business combination; at the time of the transaction, affects neither the accounting profit nor taxable profit or loss; and at the time of the transaction, does not give rise to equal taxable and deductible temporary differences.

B. In respect of deductible temporary differences associated with investments in subsidiaries, associates and joint ventures, deferred tax assets are recognized only to the extent that it is probable that the temporary differences will be reversed in the foreseeable future with sufficient taxable profit against which the temporary differences can be utilized.


Deferred tax assets and liabilities are measured at the tax rates that are expected to apply in the year when the asset is realized or the liability is settled, based on tax rates and tax laws that have been enacted or substantively enacted at the reporting date. The measurement of deferred tax assets and deferred tax liabilities reflects the tax consequences that would follow from the manner in which the Company expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities. Deferred tax relating to items recognized outside profit or loss is recognized outside profit or loss. Deferred tax items are recognized in correlation to the underlying transaction either in other comprehensive income or directly in equity. Deferred tax assets are reassessed at each reporting date and are recognized accordingly.

Deferred tax assets and deferred tax liabilities are offset, if a legally enforceable right exists to set off current income tax assets against current income tax liabilities and the deferred taxes relate to the same taxable entity and the same taxation authority.

According to the temporary exception in the International Tax Reform – Pillar Two Model Rules (Amendments to IAS 12), information about deferred tax assets and liabilities related to Pillar Two income tax will neither be recognized nor be disclosed.

5. Significant accounting judgements, estimates and assumptions

In preparation of the Company’s consolidated financial statements, the Company’s management is required to make judgments, estimates and assumptions at the end of the reporting period that affect the reported amounts of revenues, expenses, assets and liabilities, and the disclosure of contingent liabilities. Uncertainties from these assumptions and estimate may result in a material adjustment to the carrying amount of relevant assets or liabilities in future periods.

Major resources or factors that are the bases of estimates or assumptions are with uncertainties. Significant risks may exist that may result in material adjustments on the carrying amounts of assets or liabilities in future reporting periods. Major estimate factors are listed as follows:

A. Accounts receivable - estimate of impairment loss

The Company estimates the impairment loss of accounts receivable at an amount equal to lifetime expected credit loss. The credit loss is the present value of the difference between the contractual cash flows that are due under the contract (carrying amount) and the cash flows that are expected to receive (by evaluating forward looking information). However, as the impact from the discounting of short-term receivables is not material, the credit loss is measured by the undiscounted cash flows. Where the actual future cash flows are lower than expected, a material impairment loss may arise. Please refer to Notes 6(3) and (12) for more details.

38


B. Inventories

Estimates of net realizable value of inventories take into consideration that inventories may be damaged, wholly or partially obsolete, or with downward selling prices. The estimates are based on the most reliable evidence available at the time the estimates are made. Refer to Note 6(4) for details.

C. The Fair Value of Financial Instruments

Where the fair value of financial assets and financial liabilities recorded in the balance sheet cannot be derived from active markets, they are determined using valuation Techniques including the income approach (for example the discounted cash flows model) or market approach. Changes in assumptions about these factors could affect the reported fair value of the financial instruments. Please refer to Note 12 for more details.

D. Pension Benefits

The cost of post-employment benefit and the present value of the pension obligation under defined benefit pension plans are determined using actuarial valuations. An actuarial valuation involves making various assumptions, including the discount rate and expected salary raise/cut or changes. Please refer to Note 6(9) for more details.

E. Income Tax

Uncertainties exist with respect to the interpretation of complex tax regulations and the amount and timing of future taxable income. Given the wide range of international business relationships and the long-term nature and complexity of existing contractual agreements, differences arising between the actual results and the assumptions made, or future changes to such assumptions, could necessitate future adjustments to tax income and expense already recorded. The Company make provisions, based on reasonable estimates, for possible consequences of audits by the tax authorities of the respective counties in which it operates. The amount of such provisions is based on various factors, such as experience of previous tax audits and differing interpretations of tax regulations by different jurisdictional tax authorities. Such differences of interpretation may arise on a wide variety of issues depending on the conditions prevailing in the respective Company entities' domicile.

Deferred tax assets are recognized to the extent where tax loss carryforward, tax credits and deductible temporary differences that are probable with foreseeable taxable profit being available, can be utilized. The amount of deferred tax assets is estimated based upon the likely timing of utilizing taxable temporary differences and forecasted taxable profits as well as future tax planning strategies.

39


  1. Contents of significant accounts

(1) Cash and cash equivalents

As of 31 December
2025 2024
Cash on hand $57 $55
Petty cash 245 245
Demand deposits 503,763 450,369
Total $504,065 $450,669

(2) Financial assets measured at amortized cost

As of 31 December
2025 2024
Commercial paper $115,810 $ -
Pledged time deposits 2,800 2,800
Subtotal 118,610 2,800
Less: loss allowance - -
Total $118,610 $2,800
Current $115,810 $ -
Non-current 2,800 2,800
Total $118,610 $2,800

For further information on financial assets measured at amortized cost pledged as collateral and on credit risk, please refer to Note 8 and Note 12, respectively.

(3) Accounts receivable, net

As of 31 December
2025 2024
Accounts receivable (Total) $236,363 $376,194
Less: loss allowance (42) (943)
Accounts receivable (Net) $236,321 $375,251

Accounts receivable were not pledged.


The collection period is generally net 30~150 days. The carrying amount of accounts receivable of 31 December in both 2025 and 2024 has been assessed with a high likelihood of collection. Please refer to Note 6(12) for more details regarding loss allowance of accounts receivable for the year periods ended December 2025 and 2024. Please refer to Note 12 for more details on credit risk management.

100% credit loss provision is reserved for account receivables which are deemed with least possibility to be collected. As of 31 December 2025, and 2024, the receivables with 100% loss allowances being reserved amounted to $25,271 thousand and $26,247 thousand, respectively.

(4) Inventories, net

As of 31 December
2025 2024
Raw materials $154,800 $271,812
Work in progress 29,977 9,670
Finished goods 401,000 485,576
Merchandise 15,929 9,658
Total $601,706 $776,716

The cost of inventories recognized as cost of sales for the years ended 31 December 2025 and 2024 amounted to $1,904,370 thousand and $2,280,331 thousand, respectively. The expenses resulted from inventory write-downs were recorded as $64,496 thousand and $50,897 thousand for the years ended 31 December 2025 and 2024, respectively.

No inventories were pledged.


(5) Property, plant and equipment

Land Land improvements Buildings Machinery and equipment Transportation equipment Other equipment Construction in progress Total
Cost:
As of 1 January 2025 $465,109 $3,083 $1,022,169 $2,651,626 $17,651 $365,185 $ - $4,524,823
Additions - - 7,720 49,891 89 6,279 - 63,979
Disposals - - (3,566) (27,305) (675) (2,299) - (33,845)
Reclassification - - - 47,898 41 2,537 960 51,436
As of 31 December 2025 $465,109 $3,083 $1,026,323 $2,722,110 $17,106 $371,702 $960 $4,606,393
Depreciation and impairment:
As of 1 January 2025 $ - $2,443 $634,875 $2,221,829 $13,210 $272,493 $ - $3,144,850
Depreciation - 106 43,476 126,026 936 20,446 - 190,990
Disposals - - (3,526) (25,873) (675) (2,299) - (32,373)
Reclassification - - - - - - - -
As of 31 December 2025 $ - $2,549 $674,825 $2,321,982 $13,471 $290,640 $ $3,303,467
Cost:
As of 1 January 2024 $465,109 $3,083 $1,011,539 $2,594,682 $16,351 $340,857 $ - $4,431,621
Additions - - 7,997 45,918 1,300 7,330 - 62,545
Disposals - - (891) (5,663) - (4,716) - (11,270)
Reclassification - - 3,524 16,689 - 21,714 - 41,927
As of 31 December 2024 $465,109 $3,083 $1,022,169 $2,651,626 $17,651 $365,185 $ - $4,524,823

42


Land Land improvements Buildings Machinery and equipment Transportation equipment Other equipment Construction in progress Total
Depreciation and impairment:
As of 1 January 2024 $ - $2,311 $590,583 $2,091,853 $12,454 $256,524 $ - $2,953,725
Depreciation - 132 45,177 135,207 756 20,492 - 201,764
Disposals - - (885) (5,231) - (4,523) - (10,639)
Reclassification - - - - - - - -
As of 31 December 2024 $ - $2,443 $634,875 $2,221,829 $13,210 $272,493 $ - $3,144,850
Net carrying amount:
As of 31 December 2025 $465,109 $534 $351,498 $400,128 $3,635 $81,062 $960 $1,302,926
As of 31 December 2024 $465,109 $640 $387,294 $429,797 $4,441 $92,692 $ - $1,379,973

(a) There is no capitalization of interest due to purchase of property, plant and equipment for the years ended 31 December 2025 and 2024.

(b) Components of buildings that have different useful lives are the main building structure and air condition equipment and elevators, which are depreciated over 60 years and 5 years and 15 years, respectively. Machinery and equipment that have different useful lives are new reaction equipment, piping equipment, and production equipment for expansion, etc., which are depreciated over 10 years and 5 years and 7 years, respectively.

(c) As of 31 December 2025 and 2024, due to legal restrictions, part of the lands belonging to agricultural lands were recorded in the Company's accounts and the amount temporarily registered in the name of another person both amounted to $7,011 thousand without differences. The Company obtained the certificates of other rights for each of the lands.

(d) Please refer to Note 8 for property, plant and equipment pledged as collateral.


(6) Short-term loans

As of 31 December
2025 2024
Unsecured bank loans $111,181 $122,880
Secured bank loans 140,000 -
Total $251,181 $122,880
As of 31 December,
2025 2024
Interest rates applied for unsecured bank loans 1.825%~5.169% 1.825%~1.975%
Interest rates applied for secured bank loans 1.875%~1.975% -

(1) The Company’s open short-term lines of credit facilities were $461,304 thousand and $774,595 thousand as of 31 December 2025 and 2024, respectively.

(2) Please refer to Note 8 for more details on the Company’s borrowings secured by banks.

(7) Other payables

As of 31 December
2025 2024
Accrued payroll $53,421 $58,444
Accrued expense of pollution remediation 28,284 20,373
Accrued utilities expenses 7,778 10,077
Payables on equipment 6,299 5,106
Other expense 59,123 57,341
Total $154,905 $151,341

(8) Long-term loans

(a) Details of long-term loans as of 31 December 2025 and 2024 are as follows:

Lenders As of 31 December 2025 As of 31 December 2024 Redemption
First Commercial Bank secured bank loan $ - $16,600 Repayable quarterly from 5 August 2022 to 5 May 2025. Principle is repaid in 12 quarterly installments.
First Commercial Bank secured bank loan 66,640 100,000 Repayable quarterly from 7 January 2024 to 7 October 2027, after a 24-month grace period during which interest is paid monthly based on the outstanding principal. Principal is repaid in 12 quarterly installments.
Chang Hwa Commercial Bank unsecured loan - 5,625 Repayable quarterly from 24 June 2021 to 24 March 2025. Principle is repaid in 16 quarterly installments.
Taipei Fubon Bank unsecured loan - 7,500 Repayable quarterly from 1 December 2020 to 1 September 2025. Principle is repaid in 20 quarterly installments.
Taipei Fubon Bank unsecured loan 19,500 25,500 Repayable quarterly from 22 June 2024 to 22 March 2029. Principle is repaid in 20 quarterly installments.
O-Bank unsecured loan - 10,333 Repayable quarterly from 15 July 2023 to 15 July 2025. Principle is repaid in 9 quarterly installments.
O-Bank unsecured loan - 29,666 Repayable quarterly from 15 July 2023 to 15 July 2025. Principle is repaid in 9 quarterly installments.
Taiwan Cooperative Bank unsecured loan 43,750 68,750 Repayable quarterly from 19 November 2023 to 19 August 2027. Principle is repaid in 16 quarterly installments.
Hua Nan Ban unsecured loan 68,750 93,750 Repayable quarterly from 26 December 2024 to 26 September 2028. Principle is repaid in 16 quarterly installments.
Bank of Taiwan secured loan 35,417 43,750 Repayable quarterly from 29 June 2024 to 29 March 2030. Principle is repaid in 24 quarterly installments.

45


Lenders As of 31 December 2025 As of 31 December 2024 Redemption
Bank of Taiwan secured loan 49,583 61,250 Repayable quarterly from 29 June 2024 to 29 March 2030. Principle is repaid in 24 quarterly installments.
Bank of Taiwan secured loan 21,250 26,250 Repayable quarterly from 29 June 2024 to 29 March 2030. Principle is repaid in 24 quarterly installments.
Mega International Commercial Bank secured bank loan 280,000 300,000 Repayable quarterly from 26 December 2023 to 26 December 2033. A grace period of twenty-four months is granted from the date of the first drawdown. Beginning from the twenty-fifth month, the principal is repaid in 33 quarterly installments.
E.Sun Commercial Bank, Ltd. unsecured loan 7,605 13,520 Repayable quarterly from 25 January 2024 to 25 October 2028. Principle is repaid in 20 quarterly installments.
E.Sun Commercial Bank, Ltd. unsecured loan 6,670 8,280 Repayable quarterly from 25 January 2024 to 25 October 2033. Principle is repaid in 40 quarterly installments.
E.Sun Commercial Bank, Ltd. unsecured loan 11,986 14,880 Repayable quarterly from 25 January 2024 to 25 October 2033. Principle is repaid in 40 quarterly installments.
E.Sun Commercial Bank, Ltd. unsecured loan 26,861 - Repayable quarterly from 25 July 2025 to 25 April 2032. Principle is repaid in 28 quarterly installments.
Subtotal 638,012 825,654
Less: current portion (122,016) (195,038)
Total $515,996 $630,616
As of 31 December
2025 2024
Interest rates applied 2.00%~2.42% 2.00%~2.42%

(b) Please refer to Note 8 for property, plant and equipment pledged as collateral for long-term loans.


(9) Post-employment benefits

Defined contribution plan

The Company adopt a defined contribution plan in accordance with the Labor Pension Act of the R.O.C. Under the Labor Pension Act, the Company will make monthly contributions of no less than 6% of the employees' monthly wages to the employees' individual pension accounts. The Company has made monthly contributions of 6% of each individual employee's salaries or wages to employees' pension accounts.

Pension expenses under the defined contribution plan for the years ended 31 December 2025 and 2024 were $15,566 thousand and $16,695 thousand, respectively.

Defined benefits plan

The Company adopt a defined benefit plan in accordance with the Labor Standards Act of the R.O.C. The pension benefits are disbursed based on the units of service years and the average salaries in the last month of the service year. Two units per year are awarded for the first 15 years of services while one unit per year is awarded after the completion of the 15th year. The total units shall not exceed 45 units. Under the Labor Standards Act, the Company contribute an amount equivalent to 6.6% of the employees' total salaries and wages on a monthly basis to the pension fund deposited at the Bank of Taiwan in the name of the administered pension fund committee. Before the end of each year, the Company assess the balance in the designated labor pension fund. If the amount is inadequate to pay pensions on the assumption that workers meeting retirement terms will be retiring within the coming year, the Company shall make one-time contribution to the fund to eliminate the difference before the end of March in the following year.

The Ministry of Labor is in charge of establishing and implementing the fund utilization plan in accordance with the Regulations for Revenues, Expenditures, Safeguard and Utilization of the Labor Retirement Fund. The pension fund is invested in-house or under mandate, based on a passive-aggressive investment strategy for long-term profitability. The Ministry of Labor establishes checks and risk management mechanism based on the assessment of risk factors including market risk, credit risk and liquidity risk, in order to maintain adequate manager flexibility to achieve targeted return without over-exposure of risk. With regard to utilization of the pension fund, the minimum earnings in the annual distributions on the final financial statement shall not be less than the earnings attainable from the amounts accrued from two-year time deposits with the interest rates offered by local banks. Treasury Funds can be used to cover the deficits after the approval of the competent authority. As the Company does not participate in the operation and management of the pension fund, no disclosure on the fair value of the plan assets categorized in different classes could be made in accordance with paragraph 142 of IAS 19. The Company expects to contribute $3,293 thousand to its defined benefit plan during the 12 months beginning after 31 December 2025.

The average duration of the defined benefits plan obligation as of 31 December 2025 and 2024 are 9 years and 7 years, respectively.

47


Pension costs recognized in profit or loss are as follows:

For the years ended 31 December
2025 2024
Current service costs $528 $506
Past service costs (587) -
Interest income or expense (136) (41)
Gains arising from settlement (56) -
Total $(251) $465

Reconciliations of assets of the defined benefit obligation and plan assets at fair value are as follows:

As of 31 December
2025 2024
Defined benefit obligation $57,025 $59,167
Plan assets at fair value (65,766) (65,900)
Book amount of net defined benefit liabilities (assets) $(8,741) $(6,733)

Reconciliation of liabilities (assets) of the defined benefit plan are as follows:

Defined benefit obligation Fair value of plan assets Benefit liability (asset)
As of 1 January 2024 $64,358 $(66,006) $(1,648)
Current period service costs 506 - 506
Gains arising from settlement - - -
Net interest expense (income) 743 (784) (41)
Subtotal 65,607 (66,790) (1,183)
Remeasurement of the defined benefit liability (asset):
Actuarial gains and loss arising from changes in demographic assumptions (1) - (1)
Actuarial gains and loss arising from changes in financial assumptions (1,900) - (1,900)
Experience adjustments 5,596 - 5,596
Remeasurements of the defined benefit assets - (5,862) (5,862)
Subtotal 3,695 (5,862) (2,167)
Benefits paid - (3,383) (3,383)
Settlement or curtailment (10,135) 10,135 -

Defined benefit obligation Fair value of plan assets Benefit liability (asset)
As of 31 December 2024 $59,167 $(65,900) $(6,733)
Current period service costs 528 - 528
Prior period service costs (587) - (587)
Gains arising from settlement (56) - (56)
Net interest expense (income) 934 (1,070) (6,984)
Subtotal 59,986 (66,970) (6,984)
Remeasurements of the defined benefit liability (asset):
Actuarial gains and loss arising from changes in demographic assumptions 1 - 1
Actuarial gains and loss arising from changes in financial assumptions 1,071 - 1,071
Experience adjustments 5,059 - 5,059
Remeasurements of the defined benefit assets - (4,870) (4,870)
Subtotal 6,131 (4,870) 1,261
Benefits paid - (3,018) (3,018)
Settlement or curtailment (9,092) 9,092 -
As of 31 December 2025 $57,025 $(65,766) $(8,741)

The following significant actuarial assumptions are used to determine the present value of the defined benefit obligation:

As of 31 December
2025 2024
Discount rate 1.40% 1.60%
Expected rate of salary increases 2.00% 2.00%

A sensitivity analysis for significant assumption as of 31 December 2025 and 2024 is as shown below:

Effect on the defined benefit obligation
2025 2024
Increase defined benefit obligation Decrease defined benefit obligation Increase defined benefit obligation Decrease defined benefit obligation
Discount rate increase by 0.25% $ - $1,265 $ - $1,141
Discount rate increase by 0.10% - 512 - 461
Discount rate decrease by 0.10% 520 - 466 -
Discount rate decrease by 0.25% 1,314 - 1,177 -
Future salary increase by 0.25% 1,303 - 1,169 -
Future salary decrease by 0.25% - 1,260 - 1,139

The sensitivity analyses above are based on a change in a significant assumption (for example: change in discount rate or future salary), keeping all other assumptions constant. The sensitivity analyses may not be representative of an actual change in the defined benefit obligation as it is unlikely that changes in assumptions would occur in isolation of one another.

The methods and assumptions for preparing sensitivity analyses was consistent with those in the prior fiscal period.

(10) Equity

A. Common stock

As of 1 January 2024 the Company’s authorized capital was $2,500,000 thousand, divided into 250,000 thousand shares with par value of $10 each. The number of issued shares was 184,884 thousand shares, and the paid-in capital was $1,848,841 thousand.

The Company’s authorized capital was $2,500,000 thousand as of 31 December 2025, the number of issued shares was 184,884 thousand shares with par value $10 each, and the paid-in capital was $1,848,841 thousand.

In August 2007, May and December 2012, the Company issued 30,000 thousand shares, 5,000 thousand shares and 5,000 thousand shares of private placement, respectively, in accordance with Article 43-6 of the Securities Exchange Act. The closing dates of the capital increase were 7 August 2007, 30 October, and 5 December 2012. The above private shares were canceled in October 2009 as a result of a capital reduction to offset the accumulated loss, with 12,449 thousand shares canceled in proportion to the shareholding ratio. In March 2016, 5,000 thousand private shares were canceled due to the merger. In December 2020 3,383 thousand shares were canceled as a result of the capital reduction in cash refund to the shareholders.

The above private shares and their subsequent allocations are based on the delivery date of the private securities in accordance with the third paragraph of Article 43-8 of the Securities Exchange Act (26 October 2007; 5 December 2012; 10 January 2013). After three years of holding such shares, the holders may apply for approval to the governing authority under Securities Exchange Act and other relevant regulations. The shares may be freely transferred in the open market after obtaining said approval.

As of 31 December 2025, the number of outstanding private 19,168 thousand shares with par value of $10 per share, and the public offering process has not yet been processed.

50


B. Capital surplus

According to the Company Act, the capital reserve shall not be used except for making good the deficit of the Company. When a Company incurs no loss, it may distribute the capital reserves related to the income derived from the issuance of new shares at a premium or income from endowments received by the Company. The distribution could be made in cash or in the form of dividend shares to its shareholders in proportion to the number of shares being held by each of them.

As of 31 December
2025 2024
Treasury share transactions $25,170 $25,170
Premium from merger 15,188 15,188
Adjustments arising from changes in percentage of ownership in subsidiaries 1,897 1,897
Total $42,255 $42,255

C. Distribution of retained earnings and dividend policies

According to the Company's Articles of Incorporation, current year's earnings, if any, shall be appropriated in the following order:

(a) Income tax obligation
(b) Offsetting accumulated deficits, if any
(c) Set aside 10% as legal reserve. However, when the legal reserve amounts to the authorized capital, this shall not apply.
(d) Set aside or reserve special reserve in accordance with law and regulations.
(e) In combining the balance with the accumulated undistributed surplus of the previous period, the board of directors shall prepare a proposal for earnings distribution and submit it to the shareholders' meeting for a resolution distributing dividends to shareholders.

The policy of dividend distribution should reflect factors such as the current and future investment environment, fund requirements, domestic and international competition and capital budgets; as well as the interest of the shareholders, share bonus equilibrium and long-term financial planning etc. The Board of Directors shall make the distribution proposal annually and present it at the shareholders' meeting. The Company's Articles of Incorporation further provide that no more than 80% of the dividends to shareholders, if any, could be paid in the form of share dividends. Accordingly, at least 20% of the dividends must be paid in the form of cash.

51


According to the Company Act, the Company needs to set aside amount to legal reserve unless where such legal reserve amounts to the total paid-in capital. The legal reserve can be used to make good the deficit of the Company. When the Company incurs no loss, it may distribute the portion of legal serve which exceeds 25% of the paid-in capital by issuing new shares or by cash in proportion to the number of shares being held by each of the shareholders.

When the Company distributing distributable earnings, it shall set aside to special reserve, an amount equal to "other net deductions from shareholders" equity for the current fiscal year, provided that if the Company has already set aside special reserve according to the requirements for the adoption of IFRS, it shall set aside supplemental special reserve based on the difference between the amount already set aside and other net deductions from shareholders' equity. For any subsequent reversal of other net deductions from shareholders' equity, the amount reversed may be distributed from the special reserve.

The FSC on 31 March 2021 issued Order No. Jin-Guan-Cheng-Fa-Zi 1090150022, which sets out the following provisions for compliance:

On a public company's first-time adoption of the IFRS, for any unrealized revaluation gains and cumulative translation adjustments (gains) recorded to shareholders' equity that the company elects to transfer to retained earnings by application of the exemption under IFRS 1, the company shall set aside special reserve. For any subsequent use, disposal or reclassification of related assets, the Company can reverse the special reserve by the proportion of the special reserve first appropriated and distribute it. The Company's special reserve resulted from first-time adoption of IFRS on 1 January 2012 (adoption date) was $0.

Details of the 2025 and 2024 earnings distribution and dividends per share as being approved and resolved by the Board of Directors' meeting and shareholders' meeting on 6 March 2026 and 11 June 2025, respectively, are as follows:

Appropriation of earnings Dividend per share (NTD)
2025 2024 2025 2024
Legal reserve used to offset accumulated deficits $ - $(51,694) $ - $ -

Please refer to Note 6(14) for further details on employees' compensation and remuneration to directors.

52


(11) Operating revenue

The Company’s revenue mainly come from selling products the Company manufactured. Analysis of revenue from contracts with customers during the years ended 31 December 2025 and 2024 are as follows:

A. Disaggregation of revenue

For the years ended 31 December
2025 2024
Sale of goods $1,774,757 $2,286,720

The Company recognizes revenues when control of the products is transferred to customers. Revenues are earned and reported at the time that respective contract criteria are met.

B. Contract balance

Contract liabilities - current

As of
31 December 2025 31 December 2024 1 January 2024
Sales of goods $78,411 $631 $25,305

The movement in the Company’s balances of contract liabilities for the years ended 31 December 2025 and 2024 are as follows:

For the years ended 31 December
2025 2024
Revenue recognized from opening balance $(631) $(25,305)
Increase in advance receipt within the period (excluding the amount being recognized as periodical revenues) 78,411 631

C. Transaction price allocated to unfulfilled contract obligations

None.

D. Assets recognized from costs to fulfil a contract with customers

None.

53


(12) Expected credit gains

For the years ended 31 December
2025 2024
Operating expenses – Expected credit gains
Accounts receivable $1,877 $1,501

Please refer to Note 12 for more details on credit risk.

The Company measures the loss allowance of its trade receivables (includes notes receivable, accounts receivable and overdue receivables) at an amount equal to lifetime expected credit loss. The assessment of the Company’s loss allowance as of 31 December 2025 and 2024 are as follows:

31 December 2025

Not yet due (note) Overdue Total
<=30 days 31-90 days 91-180 days 181-365 days >=365 days
Gross carrying amount $243,489 $416 $ - $ - $ - $25,271 $269,176
Loss rate -% 5-10% 15-20% 40-60% 70-90% 100%
Life time expected credit loss - (42) - - - (25,271) (25,313)
Net carrying amount $243,489 $374 $ - $ - $ - $ - $243,863

31 December 2024

Not yet due (note) Overdue Total
<=30 days 31-90 days 91-180 days 181-365 days >=365 days
Gross carrying amount $374,739 $9,598 $ - $ - $ - $26,247 $410,584
Loss rate -% 5-10% 15-20% 40-60% 70-90% 100%
Life time expected credit loss - (943) - - - (26,247) (27,190)
Net carrying amount $374,739 $8,655 $ - $ - $ - $ - $383,394

Note: The Company’s notes receivable are not overdue.


The movement in the impairment provision of notes receivable, accounts receivable and overdue receivables for the years ended 31 December 2025 and 2024 is as follows:

Notes receivable Accounts receivable Overdue Receivables Total
As of 1 January 2025 $ - $943 $26,247 $27,190
Provision (Reversal) - (901) (976) (1,877)
As of 31 December 2025 $ - $42 $25,271 $25,313
As of 1 January 2024 $ - $1,710 $26,981 $28,691
Provision (Reversal) - (767) (734) (1,501)
As of 31 December 2024 $ - $943 $26,247 $27,190

(13) Leases

A. The Company as a lessee

The Company leases various properties, including land, buildings, transportation equipment and other equipment. The lease terms range from 2 to 10 years.

The impact of Company’s leases on the financial position, financial performance and cash flows is as follows:

(a) Amounts recognized in the balance sheet

(i) Right-of-use asset

Cost:

Land Buildings Transportation equipment Other equipment Total
As of 1 January 2025 $85,700 $112,132 $3,872 $ - $201,704
Additions 2,762 23,180 1,056 - 26,998
Disposals (2,619) (45,339) (2,064) - (50,022)
As of 31 December 2025 $85,843 $89,973 $2,864 $ - $178,680

Depreciation and impairment:

Land Buildings Transportation equipment Other equipment Total
As of 1 January 2025 $52,731 $54,653 $2,281 $ - $109,665
Depreciation 9,749 24,309 1,111 - 35,169
Disposals (2,618) (45,340) (2,064) - (50,022)
As of 31 December 2025 $59,862 $33,622 $1,328 $ - $94,812

Cost:

Land Buildings Transportation equipment Other equipment Total
As of 1 January 2024 $86,832 $85,439 $3,177 $108 $175,556
Additions - 34,826 695 - 35,521
Disposals (1,132) (8,133) - (108) (9,373)
As of 31 December 2024 $85,700 $112,132 $3,872 $- $201,704

Depreciation and impairment:

Land Buildings Transportation equipment Other equipment Total
As of 1 January 2024 $44,068 $37,100 $786 $101 $82,055
Depreciation 9,795 25,686 1,495 7 36,983
Disposals (1,132) (8,133) - (108) (9,373)
As of 31 December 2024 $52,731 $54,653 $2,281 $- $109,665
Net carrying amount:
As of 31 December 2025 $25,981 $56,351 $1,536 $- $83,868
As of 31 December 2024 $32,969 $57,479 $1,591 $- $92,039

(ii) Lease liabilities

As of December 31
2025 2024
Current $32,208 $29,818
Non-Current 50,238 60,550
Total $82,446 $90,368

Please refer to Note 6(15)(d) for the interest expense regarding with lease liabilities recognized during the years ended 31 December 2025 and 2024. Please refer to Note 12(5) Liquidity Risk Management for the maturity analysis on lease liabilities as of 31 December 2025 and 2024.

B. Amounts recognized in the statement of comprehensive income

Depreciation charge for right-of-use assets

For the years ended 31 December
2025 2024
Land $9,749 $9,795
Buildings 24,309 25,686
Transportation equipment 1,111 1,495
Other equipment - 7
Total $35,169 $36,983

C. Income and costs relating to leasing activities

For the years ended 31 December
2025 2024
The expenses relating to short-term leases $4,686 $4,318

D. Cash outflow relating to lessee and leasing activities

During the years ended 31 December 2025 and 2024, the Company's total cash outflows for leases amounting to $41,212 thousand and $42,248 thousand, respectively.

(14) Summary of employee benefits, depreciation and amortization expenses by function for the years ended 31 December 2025 and 2024:

| Function
Nature | For the years ended 31 December | | | | | |
| --- | --- | --- | --- | --- | --- | --- |
| | 2025 | | | 2024 | | |
| | Operating costs | Operating expenses | Total amount | Operating costs | Operating expenses | Total amount |
| Employee benefits expenses | | | | | | |
| Salaries | $227,945 | $81,402 | $309,347 | $250,369 | $82,097 | $332,466 |
| Labor and health insurance | 26,918 | 8,499 | 35,417 | 28,637 | 8,394 | 37,031 |
| Pension | 11,688 | 3,627 | 15,315 | 12,823 | 4,336 | 17,159 |
| Directors' remuneration | - | 1,714 | 1,714 | - | 1,650 | 1,650 |
| Other employee benefits expense | 16,903 | 4,180 | 21,083 | 18,585 | 4,224 | 22,809 |
| Depreciation | 210,439 | 15,720 | 226,159 | 221,214 | 17,533 | 238,747 |
| Amortization | 3,343 | 3,708 | 7,051 | 4,163 | 3,103 | 7,266 |

The number of employees of the Company in 2025 and 2024 was 447 and 481, respectively, including 4 non-employee directors.

The Company's average employee benefit expenses for 2025 and 2024 were $860 thousand and $858 thousand, respectively.

The Company's average employee salary expenses for 2025 and 2024 were $698 thousand and $697 thousand, respectively.

The Company's average employee salary expenses in 2025 increased by approximately $0.14\%$, compared to 2024.


Article 19 of the Company's articles of incorporation stipulates that when directors perform their duties in the Company, regardless of the Company's operating profit or loss, the Company shall pay remuneration to the directors. The board shall determine the remuneration according to the industry level and negotiated according to the value of their participation in the Company's operations and contribution. Article 30 of the Company's articles of association provides that the director's remuneration shall be determined at a rate of no more than 1% when profits are made in the current year and refer to the results of director's performance evaluation as the basis for individual remuneration. The amount of director's remuneration shall be submitted to the general meeting of shareholders after the resolution of the board of directors is passed.

The Company's remuneration principle is to provide market-competitive remuneration to attract and cultivate talents in the long term. The Company formulates "Salary Management Measures" and "Employee Performance Appraisal Procedures" as the basis for evaluation by mainly referring to the salary level in the inter-industry market. Furthermore, the Company considers the overall operating conditions and profitability levels to determine reasonable remuneration based on the results of performance appraisals. The related performance appraisal results and remuneration reasonableness are reported to the compensation committee and the board of directors for review.

According to the Articles of Incorporation, at least 3% of profit of the current year shall be appropriated as employees' compensation (of which no less than 1.5% of profit shall be distributed to non-managerial employees), and no higher than 1% of profit of the current year shall be appropriated as remuneration to board directors, however, the accumulated deficits, if any, shall first be made up for. The Company may, by a resolution adopted by a majority vote at a meeting of Board of Directors attended by two-thirds of the total number of directors, have the profit distributable as employees' compensation in the form of shares or cash; and in addition thereto a report of such distribution is submitted to the shareholders' meeting. Information on the Board of Directors' resolution regarding the employees' compensation and remuneration to directors and supervisors can be obtained from the "Market Observation Post System" on the website of the TWSE.

For the years ended 31 December 2025 and 2024, the Company incurred net operating losses, and accordingly no employees' compensation or remuneration to board directors was recognized.

58


(15) Non-operating income and expenses

A. Interest income

For the years ended 31 December
2025 2024
Financial assets measured at amortized cost $3,564 $5,390

B. Other income

For the years ended 31 December
2025 2024
Dividend income $2,226 $2,778
Rental income 656 656
Others 4,365 4,006
Total $7,247 $7,440

C. Other gains and losses

For the years ended 31 December
2025 2024
Foreign exchange (loss) gain, net $(9,806) $11,925
Loss on disposal of property, plant and equipment (992) (364)
Gain (loss) on valuation of financial assets (liabilities) at fair value through profit or loss (Note) 527 (402)
Others expense (39) (24)
Total $(10,310) $11,135

Note: Balances were arising from valuation adjustments of financial assets (liabilities) mandatorily measured at fair value through profit or loss.

D. Finance costs

For the years ended 31 December
2025 2024
Interest on bank loans $(19,096) $(25,754)
Interest on lease liabilities (1,606) (1,471)
Total $(20,702) $(27,225)

(16) Components of other comprehensive income (loss)

A. For the year ended 31 December 2025

Arising during the period Reclassification adjustments during the period Other comprehensive income (loss), before tax Income tax effect Other comprehensive income (loss), net of tax
Items not to be reclassified to profit or loss subsequently:
Remeasurements of defined benefit plans $(1,261) $ - $(1,261) $252 $(1,009)
Unrealized gains from equity instruments investments measured at fair value through other comprehensive income 49,328 - 49,328 - 49,328
Total of other comprehensive income $48,067 $ - $48,067 $252 $48,319

B. For the year ended 31 December 2024

Arising during the period Reclassification adjustments during the period Other comprehensive income (loss), before tax Income tax effect Other comprehensive income (loss), net of tax
Items not to be reclassified to profit or loss subsequently:
Remeasurements of defined benefit plans $2,167 $ - $2,167 $(433) $1,734
Unrealized gains from equity instruments investments measured at fair value through other comprehensive income 11,797 - 11,797 - 11,797
Total of other comprehensive income $13,964 $ - $13,964 $(433) $13,531

(17) Income tax

The major components of income tax (expense) benefit for the years ended 31 December 2025 and 2024 are as follows:


A. Income tax (expense) benefit recognized in profit or loss

For the years ended 31 December
2025 2024
Current income tax benefit (expense):
Current income tax charge $ - $ -
Adjustments in respect of current income tax of prior periods 2,966 -
Deferred tax expense:
Deferred tax expense relating to origination and reversal of temporary differences 11,724 3,309
Total income tax benefit (expense) $14,690 $3,309

B. Income tax relating to components of other comprehensive income

For the years ended 31 December
2025 2024
Deferred income tax benefit (expense):
Remeasurements of defined benefit plans $252 $(433)
Income tax relating to components of other comprehensive income $252 $(433)

C. Reconciliation between tax expense and the product of accounting profit multiplied by applicable tax rates is as follows:

For the years ended 31 December
2025 2024
Accounting loss before tax from continuing operations $(354,329) $(185,885)
Income tax calculated at the Company's statutory income tax rate $70,866 $37,177
Tax effect of revenues exempt from taxation (445) (556)
Tax effect of expenses not deductible for tax purposes 756 894
Tax effect of deferred tax assets/liabilities (53,521) (34,206)
Adjustments in respect of income tax (expense) of prior periods (2,966) -
Total income tax benefit (expense) recognized in profit or loss $14,690 $3,309

D. Significant components of deferred tax assets (liabilities) are as follows:

(a) For the year ended 31 December 2025

Beginning balance as of 1 January Recognized in profit or loss Recognized in other comprehensive income Ending balance as of 31 December
Temporary difference
Allowance for inventory valuation loss $34,751 $12,899 $ - $47,650
Actuarial gains (losses) on pension (454) - 252 (202)
Land value appreciation tax (72,514) - - (72,514)
Accrued pollution remediation expense 30,451 (1,790) - 28,661
Loss carry-forward 17,371 - - 17,371
Others 1,399 615 - 2,014
Deferred income tax benefit (expense) $11,724 $252
Net deferred income tax assets/(liabilities) $11,004 $22,980
Balances as of 31 December 2025:
Deferred tax assets $84,133 $95,494
Deferred tax liabilities $(73,129) $(72,514)

(b) For the year ended 31 December 2024

Beginning balance as of 1 January Recognized in profit or loss Recognized in other comprehensive income Ending balance as of 31 December
Temporary difference
Allowance for inventory valuation loss $24,572 $10,179 $ - $34,751
Actuarial gains (losses) on pension (21) - (433) (454)
Land value appreciation tax (72,514) - - (72,514)
Accrued pollution remediation expense 32,029 (1,578) - 30,451
Loss carry-forward 17,371 - - 17,371
Others 6,691 (5,292) - 1,399
Deferred income tax benefit/(expense) $3,309 $(433)
Net deferred income tax assets/(liabilities) $8,128 $11,004
Balances on 31 December 2024:
Deferred tax assets $80,642 $84,133
Deferred tax liabilities $(72,514) $(73,129)

E. The following table provides the information of the unused loss carry-forward:

Year Tax loss for the period Unused tax loss as of Expiration Year
31 December 2025 31 December 2024
2020 $163,132 $86,855 $86,855 2030
2021 76,486 76,486 76,486 2031
2023 231,854 231,854 231,854 2033
2024 171,717 171,717 171,717 2034
2025 297,750 297,750 - 2035
Total $904,939 $864,662 $566,912

F. Unrecognized deferred assets

As of 31 December 2025, and 2024, deductible temporary differences for which no deferred income tax assets have been recognized in amounted to $173,301 thousand and $113,848 thousand, respectively.

G. The assessment of income tax returns

As of 31 December 2025, the status of the Company's income tax returns has been assessed and approved up to 2023 by tax authorities.

(18) Earnings per share

Basic earnings per share amounts are calculated by dividing net profit for the years attributable to ordinary equity holders of the parent entity by the weighted average number of ordinary shares outstanding during the year.

Diluted earnings per share amounts are calculated by dividing the net profit attributable to ordinary equity holders of the parent entity by the weighted average number of ordinary shares outstanding during the year plus the weighted average number of ordinary shares that would be issued on conversion of all the dilutive potential ordinary shares into ordinary shares.

No diluted earnings per share in 2025 shall be accounted for due to that net loss was concluded for the fiscal


64

For the years ended 31 December
2025 2024
(1) Basic earnings (loss) per share
Net (loss) attributable to the parent company (in thousand NT$) $(339,639) $(182,576)
Weighted average number of ordinary shares outstanding for basic earnings per share (in thousands) 184,884 184,884
Basic (loss) per share (NT$) $(1.84) $(0.98)

The Company’s diluted loss per share is consistent with its basic loss per share.

There were no transactions which may significantly change the number of the outstanding ordinary shares from the financial statement date to the date of releasing financial statements.

7. Related party transactions

Information of the related parties that had transactions with the Company during the financial reporting period is as follows:

Name and nature of relationship of the related parties

Name of the related parties Nature of relationship of the related parties
KT Investment Company, Limited Corporate chairman
Macy Investment Company, Limited Corporate chairman’s representative as director
Chiaoli Investment Company, Limited Corporate chairman’s representative as director
Kuo Ching Development Corp. Corporate subsidiary

Significant transactions with the related parties

A. Sales

For the years ended 31 December
2025 2024
KT Investment Company, Limited $ - $8,462

The sales price for related parties and payment condition of the Company's are set by both parties with reference to market conditions.


B. Lease - related parties

(a) Rental income

For the years ended 31 December
2025 2024
KT Investment Company, Limited $549 $549

The Company's leased its plant and building to the said related party, from which rental income and collection were set at arm's length range.

(b) Right-of-use assets

As of 31 December
2025 2024
Macy Investment Company, Limited $24,143 $32,665

(c) Lease liabilities

As of 31 December
2025 2024
Macy Investment Company, Limited $24,634 $33,351

(d) Interest expenses

For the years ended 31 December
2025 2024
Macy Investment Company, Limited $426 $551

C. Key management personnel compensation

For the years ended 31 December
2025 2024
Short-term employee benefits $9,698 $9,723
Post-employment benefits 261 255
Total $9,959 $9,978

66

8. Assets pledged as collaterals

The following table lists assets of the Company pledged as collaterals:

Carrying Amount
As of 31 December 2025 As of 31 December 2024 Purpose of pledges
Property, plant and equipment - buildings, machinery and equipment $491,085 $494,203 Long and short-term loans
Financial assets measured at amortized cost - non-current 2,800 2,800 Energy resources guarantee
Total $493,885 $497,003

9. Significant contingencies and unrecognized contractual commitments

The following items are the contingencies which have not been accrued and recorded on the balance sheet as of 31 December 2025

As of 31 December 2025, the amount available under unused letter of credit was $9,683 thousand.

10. Significant disaster loss

None.

11. Significant subsequent events

None.

12. Others

(1) Categories of financial instruments

As of 31 December
Financial Assets 2025 2024
Financial assets at fair value through other comprehensive income - non-current $47,003 $110,515
Financial assets measured at amortized cost:
Cash and cash equivalents (excluding cash on hand) 503,763 450,369
Financial assets measured at amortized cost 118,610 2,800
Notes receivable 7,542 8,143
Accounts receivables (including related parties) 236,321 375,251
Other receivables(classified as other current assets) 1,802 983
Subtotal 868,038 837,546
Total $915,041 $948,061

As of 31 December
Financial Liabilities 2025 2024
Financial liabilities at fair value through profit or loss - current $145 $402
Financial liabilities at amortized cost:
Short-term loans 251,181 122,880
Notes and accounts payable 156,235 213,483
Other payables 154,905 151,341
Long-term loans (including current portion) 638,012 825,654
Lease liabilities 82,446 90,368
Subtotal 1,282,779 1,403,726
Total $1,282,924 $1,404,128

(2) Financial risk management objectives

The Company's principal financial risk management objective is to manage the market risk, credit risk and liquidity risk related to its operating activities. The Company identifies measures and manages the aforementioned risks based on the Company's policy and risk preference.

The Company has established appropriate policies, procedures and internal controls for financial risk management. Before entering into significant activities, approval process by the board of directors and audit committee must be carried out based on related protocols and internal control procedures. The Company complies with its financial risk management policies at all times.

(3) Market risk

Market risk is the risk that the fair value or future cash flows of a financial instrument will fluctuate because of changes in market prices. Market risks comprise currency risk, interest rate risk and other price risk (such as equity risk).

In practice, it is rarely the case that a single risk factor varies independently from other risk factors. A correlation normally exist among risk factors. However, the following sensitivity analyses do not disclose the correlations among these risk factors.

Foreign currency risk

The Company's exposure to the risk of changes in foreign exchange rates relates primarily to the Company's operating activities (when revenue or expenses are denominated in a different currency from the Company's functional currency) and the Company's net investments in foreign subsidiaries.


The Company applies natural hedges on the foreign currency risk arising from purchases or sales as certain portion of receivables or payables are denominated as the same currencies, and utilizes spot or forward exchange contracts to manage foreign currency risk. The Company designates certain forward currency contracts as balance sheet hedges to hedge its exposure to foreign currency exchange risk associated with certain balance sheet assets or liabilities. Hedge accounting is not applied as the aforesaid natural hedges or designated forward contracts to hedge currency risk are deemed ineffective hedges. Furthermore, the currency risk exposures due from investments in oversea associates are not hedges as the investments are set for certain operating strategies.

The foreign currency sensitivity analysis of the possible change in foreign exchange rates on the Company's profit is performed on significant monetary items denominated in foreign currencies as at the end of the reporting period. The Company's foreign currency risk mainly resulted from the volatility of exchanging USD, CNY to NTD, and vice versa. The information of the sensitivity analysis is as follows:

a. When NTD strengthens/weakens against USD by 1%, the profit for the years ended 31 December 2025 and 2024 is decreased / increased by $989 thousand and $2,552 thousand, respectively; and no impact on the equity.

b. When NTD strengthens/weakens against CNY by 1%, the profit for the years ended 31 December 2025 and 2024 is decreased / increased by $80 thousand and by $56 thousand, respectively; and no impact on the equity.

Interest rate risk

The Company is exposed to interest rate risk arising from borrowing at floating interest rates. Interest rate risk is the risk that the fair value or forecasted cash flows of a financial instrument fluctuates due to the volatility in market interest rates.

The sensitivity analysis of interest rate fluctuation is performed on items exposed to interest rate risk as at the end of the reporting period, including borrowings with variable interest rates. At the reporting dates, a change of 10 basis points of interest rate in a reporting period could cause the profit for the years ended 31 December 2025 and 2024 to decreased / increased by $889 thousand and $949 thousand, respectively.

Equity price risk

The Company's listed and unlisted equity securities are susceptible to market price risk arising from uncertainties about future performance of equity markets. The Company's equity investments are classified as financial assets at fair value through other comprehensive income. The equity investment portfolio is submitted to the Company's senior management on a regular basis. The Company's Board of Directors reviews and approves changes on the equity investment portfolio.

68


At the reporting date, for equity investments in the listed companies which are recorded as financial assets at fair value through other comprehensive income, an increase/decrease of 10% in the share price could increase/decrease $0 thousand and $634 thousand for the years ended 31 December 2025 and 2024, respectively

Please refer to Note 12(9) for sensitivity analysis information of other equity instruments or derivatives that are linked to such equity instruments whose fair value measurement is categorized under Level 3.

(4) Credit risk management

Credit risk is the risk that a financial loss may be triggered when a counterparty defaults its obligations. The Company is exposed to credit risk from operating activities (primarily for, accounts receivable and notes receivable) and from its financing activities, including bank deposits and other financial instruments.

The Company mitigates credit risks by implementing the Company’s credit policy, procedures and controls. Credit limits are set for all counter parties based on their financial positions, credit ratings, historical experience, prevailing economic condition and the Company’s internal rating criteria etc. For dealing with some counterparties with less credit, certain financial instruments of credit enhancement, such as advance receipts or a letter of credit, may be required to be provided to mitigate possible credit risk exposures.

As of 31 December 2025 and 2024, accounts receivable from top ten customers represent 70% and 55% of the total accounts receivable of the Company, respectively. The credit concentration risk of other trade receivables is insignificant.

Credit risk from deposits in banks, fixed income securities and other financial instruments is managed by the Company’s treasury division in accordance with the Company’s policy. The Company only deals with counterparties that are approved through internal control procedures; therefore, the counterparties are limited to banks, financial institutions, companies or government entities with good credit standing.

The Company would write down or write off values of financial assets if these are forecasted to be least possible to be collected in the case of the issuer or debtor being insolvent or in financial distress.

69


(5) Liquidity risk management

The Company’s objective is to maintain a balance between continuity of funding and flexibility through the use of cash and cash equivalents, highly liquid equity investments and bank borrowings. The table below summarizes the maturity profile of the Company’s financial liabilities based on the contractual undiscounted payments and contractual maturity, including contractual interests. The undiscounted interest payment due from borrowings with variable interest rates is extrapolated based on the estimated interest rate yield curve as of the end of the reporting period.

Non-derivative financial liabilities

Less than 1 year 2 to 3 years 4 to 5 years >= 5 years Total
As of 31 December 2025
Short-term loans $258,312 $ - $ - $ - $258,312
Notes and accounts payable 156,235 - - - 156,235
Long-term loans 124,643 230,817 108,852 219,009 683,321
Lease liabilities 33,506 47,182 4,092 - 84,780
As of 31 December 2024
Short-term loans $125,186 $ - $ - $ - $125,186
Notes and accounts payable 213,483 - - - 213,483
Long-term loans 199,187 288,885 143,297 249,534 880,903
Lease liabilities 31,197 42,969 15,219 - 89,385

Derivative financial assets (liabilities)

Less than 1 year 2 to 3 years 4 to 5 years >= 5 years Total
As of 31 December 2025
Inflows $18,983 $ - $ - $ - $18,983
Outflows (19,128) - - - (19,128)
Net $(145) $ - $ - $ - $(145)
As of 31 December 2024
Inflows $31,299 $ - $ - $ - $31,299
Outflows (31,701) - - - (31,701)
Net $(402) $ - $ - $ - $(402)

(6) Reconciliation of liabilities arising from financing activities

Reconciliation of liabilities for the year ended 31 December 2025:

Short-term loans Long-term loans (including current portion) Lease liabilities Total liabilities from financing activities
As of 1 January 2025 $122,880 $825,654 $90,368 $1,038,902
Cash flows 128,301 (187,642) (34,920) (94,261)
Non-cash changes - - 26,998 26,998
As of 31 December 2025 $251,181 $638,012 $82,446 $971,639

Reconciliation of liabilities for the year ended 31 December 2024:

Short-term loans Long-term loans (including current portion) Lease liabilities Total liabilities from financing activities
As of 1 January 2024 $162,912 $908,582 $92,398 $1,163,892
Cash flows (40,032) (82,928) (36,459) (159,419)
Non-cash changes - - 34,429 34,429
As of 31 December 2024 $122,880 $825,654 $90,368 $1,038,902

(7) Fair value of financial instruments

A. Valuation methodology and assumptions for fair values

Fair value is the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction among market participants at the measurement date. The following are the methodology and assumptions taken by the Company to measure or disclose the fair values of financial assets and financial liabilities:

(a) The carrying amount of cash and cash equivalents, accounts receivable, accounts payable and other current liabilities approximate their fair value due to their short maturities.


(b) For financial assets and liabilities traded in an active market with standard terms and conditions, their fair value is determined based on market quoted prices (including listed equity securities) at the reporting date.

(c) Fair value of equity instruments without market quoted prices (including private placement of listed equity securities, unquoted public Company and private Company equity securities) are valued by market approach which takes industrial comparable entities' quoted market prices or other relevant information as reference to estimate probable fair values.

(d) Fair value of debt instruments without market quoted prices, bank loans, and other non-current liabilities are determined based on the counterparties prices or valuation method. The valuation method uses DCF method as a basis, and the assumptions such as interest rates and discount rate are primarily based on relevant information of equivalent instruments (such as yield curves published by the Taipei Exchange, average prices and credit risks for Fixed Rate Commercial Paper published by Reuters, etc.)

B. Fair value of financial instruments measured at amortized cost

The carrying amount of the Company's financial instruments, financial assets and liabilities measured at amortized cost approximate their fair value.

C. Fair value measurement hierarchy for financial instruments

Please refer to Note 12(9) for fair value measurement hierarchy for financial instruments of the Company.

(8) Derivative financial instruments

The related information for the Company's derivative instruments not qualified for hedge accounting and not yet settled as of 31 December 2025 and 2024 is as follows:

Forward currency contracts

The Company entered into forward currency contracts to mitigate its exposure to financial risk, but these contracts are not designated as hedging instruments. The table below lists the information related to forward currency contracts:

Items (by contract) Notional Amount Contract Period
As of 31 December 2025 Sell USD 610 thousand From 2025.11.13 to 2026.03.06
Forward currency contract
As of 31 December 2024 Sell USD 970 thousand From 2024.11.06 to 2025.03.21
Forward currency contract

(9) Fair value measurement hierarchy

A. Fair value measurement hierarchy

All asset and liabilities for which fair values are measured or disclosed in the financial statements are categorized within the fair value hierarchy, based on the lowest level input that is significant to the fair value measurement as a whole. Level 1, 2 and 3 inputs are described as follows:

Level 1 - Quoted (unadjusted) market prices in active markets for identical assets or liabilities;

Level 2 - Valuation techniques for which the lowest level input that is significant to the fair value measurement is directly or indirectly observable;

Level 3 - Valuation techniques for which the lowest level input that is significant to the fair value measurement is unobservable.

For assets and liabilities that are recognized in the financial statements on a recurring basis, the Company determines whether transfers have occurred between levels in the hierarchy by re-assessing categorization at the end of each reporting period.

B. Fair value measurement hierarchy of the Company's assets and liabilities

The Company does not have assets that are measured at fair value on a non-recurring basis. Fair values of the Company's assets and liabilities are measured at fair value on a recurring basis as follows:

As of 31 December 2025

Level 1 Level 2 Level 3 Total
Financial assets:
Financial assets at fair value through other comprehensive income
Equity instrument measured at fair value through other comprehensive income $ - $ - $47,003 $47,003
Financial liabilities:
Financial liabilities at fair value through profit or loss
Forward foreign exchange contracts $ - $145 $ - $145

As of 31 December 2024

Level 1 Level 2 Level 3 Total
Financial assets:
Financial assets at fair value through other comprehensive income
Equity instrument measured at fair value through other comprehensive income $6,337 $ - $104,178 $110,515
Financial liabilities:
Financial liabilities at fair value through profit or loss
Forward foreign exchange contracts $ - $402 $ - $402

Re-classifications between Level 1 and Level 2 during the period

During the years ended 31 December 2025 and 2024, there were no re-classifications between Level 1 and Level 2 fair value measurements.

Reconciliation for fair value measurements in Level 3 of the fair value hierarchy for movements during the period is as follows:

Assets
At fair value through other comprehensive income
Stocks
For the years ended 31 December
2025 2024
Beginning balances $104,178 $93,831
Total gains (losses) recognized:
Amount recognized in OCI (classified under “Unrealized (losses) gains from equity instruments measured at fair value through other comprehensive income) 3,848 10,347
Disposal (61,023) -
Ending balances $47,003 $104,178

Information on significant unobservable inputs of fair value measurement in Level 3 fair value hierarchy

Significant unobservable inputs of fair value measurement in Level 3 fair value hierarchy are as follows:


As of 31 December 2025

Valuation techniques Significant unobservable inputs Quantitative information Correlation between inputs and fair value Sensitivity Analysis of correlation between inputs and fair value
Financial assets:
Financial assets at fair value through other comprehensive income
Stocks Asset approach discount for lack of marketability 30% The greater degree of lack of marketability, the lower the estimated fair value is determined. 10% increase (decrease) in the discount for lack of marketability would result in (decrease) increase in the Company’s profit or loss by $4,700 thousand

As of 31 December 2024

Valuation techniques Significant unobservable inputs Quantitative information Correlation between inputs and fair value Sensitivity Analysis of correlation between inputs and fair value
Financial assets:
Financial assets at fair value through other comprehensive income
Stocks Asset approach discount for lack of marketability 30% The greater degree of lack of marketability, the lower the estimated fair value is determined. 10% increase (decrease) in the discount for lack of marketability would result in (decrease) increase in the Company’s profit or loss by $10,418 thousand

Valuation process used for fair value measurements categorized within Level 3 of the fair value hierarchy

The Company’s treasury division is responsible for validating the fair value measurements and ensuring that the results of the valuation are in line with market conditions, based on independent and reliable inputs which are consistent with other information, and represent reasonable prices. The team analyses the movements in the values of assets and liabilities which are required to be re-measured or re-assessed as per the Company’s accounting policies at each reporting date.


(10) Significant assets and liabilities denominated in foreign currencies

Information regarding the significant assets and liabilities denominated in foreign currencies is listed below:

As of 31 December
2025 2024
Foreign Currency Exchange rate NTD Foreign Currency Exchange rate NTD
Financial assets
Monetary item:
USD $6,193 31.43 $194,646 $9,025 32.79 $295,930
CNY 1,770 4.50 7,965 1,240 4.48 5,555
Financial liabilities
Monetary item:
USD $3,046 31.43 $95,736 $1,244 32.79 $40,791

The Company’s foreign exchange (losses) gains for the years 2025 and 2024 were $(9,806) and $11,925, respectively.

(11) Capital management

The primary objective of the Company’s capital management is to ensure that it maintains a strong credit rating and healthy capital ratios in order to support its business and maximize the shareholder value. To maintain or adjust the capital structure, the Company may adjust dividend payment to shareholders, return capital to shareholders or issue new shares.

  1. Other disclosures

(1) Information at significant transactions

A. Financing provided: None.
B. Endorsement/Guarantee provided: None.
C. Material securities held as at end of the period (excluding subsidiaries or an associate, and the portion held due to an interest in a joint venture):


Holding Company Type and name of securities Relationship Financial statement account As of 31 December 2025 Note
Shares Carrying amount Percentage of Shares
SUNKO INK CO., LTD LINCO TECHNOLOGY CO. LTD Unrelated party Financial assets at fair value through other comprehensive income-non-current 415,548 $8,846 0.50% $8,846
THE FIRST LEASING CORPORATION Unrelated party Financial assets at fair value through other comprehensive income-non-current 3,901,981 38,157 12.97% 38,157
GLOBAL GRAPHENE GROUP, INC. Unrelated party Financial assets at fair value through other comprehensive income-non-current 6,155 - 0.87% -
YAYI CO., LTD. Unrelated party Financial assets at fair value through other comprehensive income-non-current 368,898 - 1.85% -
KING SHINE EE TECHNOLOGY ENTERPRISE CO., LTD. Unrelated party Financial assets at fair value through other comprehensive income-non-current 1,000 - 0.01% -
POWER RICH Unrelated party Financial assets at fair value through other comprehensive income-non-current 1 - 0.05% -
Total $47,003 $47,003

D. Related party transactions for purchases and sales amounts exceeding the lower of $100 million or 20% of the capital stock for the period: None.

E. Receivables from related parties with amounts exceeding the lower of $100 million or 20% of capital stock as at end of the period: None.

F. Significant intercompany transactions among consolidated entities are as follows: None.

(2) Information on investees

Investees' names, locations, main businesses and products, original investment amount, investment as at end of the period, net income (loss) of the investees and investment income (loss) recognized for the period:


Investor Company Investee Company Address Main businesses and products Initial investment amount Investment as at end of the period Net income (loss) of investee Company Investment income (loss) recognized Note
Ending balance Beginning balance Number of shares (in thousands) Percentage of ownership (%) Carrying value
The Company Sunko Biotech Co. Taiwan Biotechnology Services $60,000 $60,000 1,674,044 22.32% $ - $ - $ -
The Company Chen Chi Technology Co. Taiwan Synthetic resin and plastic manufacturing $14,360 $14,360 1,640,000 41.00% $ - $ - $ -
The Company Kuo Ching Development Corp Taiwan Wholesale of chemical solvents, industrial additives, other raw materials and their products $2,000 $2,000 200,000 100% $1,624 $9 $9

(3) Information on investments in Mainland China

Significant transactions with investee companies in Mainland China directly or indirectly through third parties: None.


79

The Contents of Statements of Major Accounting Items

For the year ended 31 December 2025

Item Index
Statement of Cash and Cash Equivalents 1
Statement of Accounts Receivable 2
Statement of Inventories 3
Statement of Financial Assets at Fair Value Through Other Comprehensive Income, Noncurrent 4
Statement of Changes in Property, Plant and Equipment Note 6 (5)
Statement of Changes in Accumulated Depreciation of Property, Plant and Equipment Note 6 (5)
Statement of Changes in Right-of-Use Assets Note 6 (13)
Statement of Changes in Accumulated Depreciation of Right-of-Use Assets Note 6 (13)
Statement of Short-term Loans 5
Statement of Accounts Payable 6
Statement of Other Payables Note 6 (7)
Statement of Long-term Loans Note 6 (8)
Statement of Operating Revenues 7
Statement of Operating Costs 8
Statement of Manufacturing Overheads 9
Statement of Operating Expenses 10
Statement by Function of Employee Benefits, Depreciation and Amortization Expenses Note 6 (14)
Statement of Non-Operating Income and Expenses Note 6 (15)

SUNKO INK CO., LTD.
1. Statement of Cash and Cash Equivalents
31 December 2025
Unit: Thousands of NTD

Item Description Amount Note
Cash $302
Cash in banks
Currency deposits USD $3,292 exchange rate 31.43 103,463
CNY $590 exchange rate 4.496 2,653
EUR $1 exchange rate 36,90 1
JPY $16,030 exchange rate 0.2008 3,219
Demand deposits 275,427
Deposits account 119,000
Total $504,065

SUNKO INK CO., LTD.
2. Statement of Accounts Receivable
31 December 2025
Unit: Thousands of NTD

Client Name Description Amount Note
Client A $36,378
Client B 34,038
Client C 20,219
Client D 19,992
Client E 19,827
Client F 17,869
Client G 12,594
Client H 12,488
Others (Note) 61,626
Subtotal 235,031
Less: loss allowance (42)
Add: Allowance of gain on exchange 1,332
Total $236,321

Note: The amount of individual client grouped in others does not exceed 5% of the account balance.

80


SUNKO INK CO., LTD.
3. Statement of Inventories
31 December 2025
Unit: Thousands of NTD

Item Description Cost Net Realizable Value Note
Raw materials $259,630 $154,800 Please refer to Note 4(10) for more details on net realizable value
Work in process 30,206 29,977
Finished goods 533,234 401,000
Merchandise 16,889 15,929
Total 839,959 $601,706
Less: Allowance for inventory valuation loss (238,253)
Net Amount $601,706

81


SUNKO INK CO., LTD.
4. Statement of Financial Assets at Fair Value Through Other Comprehensive Income, Non-current
For the year ended 31 December 2025
Unit: Thousands of NTD

Name of Securities As of 1 January 2025 Additions Decrease Adjustments As of 31 December 2025 Accumulated impairment Collateral Note
Shares Fair Value Shares Amount Shares Amount Shares Fair Value
CHING FENG HOME FASHIONS. CO. LTD 219,666 $6,337 - $ - (219,666) $(6,337) $ - - $ - N/A None
LINCO TECHNOLOGY CO. LTD 515,044 11,695 51,504 - (151,000) (3,050) 201 415,548 8,846 N/A None
THE FIRST LEASING CORPORATION 3,422,790 34,510 479,191 - - - 3,647 3,901,981 38,157 N/A None
TOTAL ACRYLIC POLYMER INDUSTRY (TAPI) CORPORATIO 100,000 15,473 - - (100,000) (15,473) - - - N/A None
GLOBAL GRAPHENE GROUP, INC. 6,155 - - - - - - 6,155 - N/A None
YAYI CO., LTD 368,898 - - - - - - 368,898 - N/A None
SAR TECHNOLOGY INC. 4,250,000 42,500 - - (4,250,000) (42,500) - - - N/A None
KING SHINE EE TECHNOLOGY ENTERPRISE CO., LTD. 1,000 - - - - - - 1,000 - N/A None
POWER RICH 1 - - - - - - 1 - N/A None
Total $110,515 $ - $(67,360) $3,848 $47,003

82


SUNKO INK CO., LTD.
5. Statement of Short-term Loans
31 December 2025
Unit: Thousands of NTD

Type Lenders Amount Contract Period Range of Interest Rates (%) Loan Facility Collateral Note
Operation purposes Mega Bank $57,464 2025.07.22-2026.05.20 4.56%-5.02% 200,000 N
Operation purposes Taiwan Cooperative Bank 24,173 2025.07.18-2026.03.17 4.32%-5.06% 250,000 N
Operation purposes First Bank 14,335 2025.11.20-2026.03.16 1.825% 480,000 N Note
Operation purposes First Bank 60,000 2025.10.03-2026.10.02 1.975% 480,000 Y Note
Operation purposes Hua Nan Commercial Bank 80,000 2025.12.26-2026.03.26 1.875% 200,000 Y
Operation purposes Taipei Fubon Commercial Bank 10,000 2025.11.07-2026.05.06 2.71% 90,000 N
Operation purposes Bank of Taiwan 1,411 2025.07.31-2026.02.26 4.68%-5.169% 200,000 N
Operation purposes Chang Hwa Commercial Bank 1,098 2025.12.30-2026.04.29 4.63% 100,000 N
Subtotal 248,481
Add:Allowance of loss on exchange 2,700
Total $251,181

Note: The short-term credit facility with First Commercial Bank is a shared credit line with a total financing limit of $480,000 thousand.


SUNKO INK CO., LTD.
6. Statement of Accounts Payable
31 December 2025
Unit: Thousands of NTD

Supplier Name Description Amount Note
Supplier A $10,227
Supplier B 35,138
Supplier C 23,114
Others (Note) 87,560
Subtotal 156,039
Add: Allowance of loss on exchange 92
Total $156,131

Note: The amount of individual supplier in others does not exceed 5% of the account balance.

SUNKO INK CO., LTD.
7. Statement of Operating Revenues
For the year ended 31 December 2025
Unit: Thousands of NTD

Item Description Amount Note
Fine Chemicals $1,014,978
Agrochemicals 473,924
Polymer-TPU&Polymer-TPV 199,564
Polymer-PU 72,204
Others 14,087
Total $1,774,757

84


SUNKO INK CO., LTD.

  1. Statement of Operating Costs

For the year ended 31 December 2025

Unit: Thousands of NTD

Item Amount
Direct Raw material
Beginning balance of raw material $310,393
Add: Raw material purchased 753,535
Transferred from work-in-process 586,930
Less: Ending balance of raw materials (259,630)
Cost of raw materials sold (2,468)
Transferred to expenses (24,242)
Others (6,990)
Raw material used 1,357,528
Direct labor 123,326
Manufacturing overheads (Statement 9) 568,325
Manufacturing cost 2,049,179
Add: Beginning balance of work in process 9,811
Outsourcing 29,131
Less: Ending balance of work in process (30,206)
Transferred to materials (586,930)
Others (179)
Cost of finished goods 1,470,806
Add: Beginning balance of finished goods 619,937
Less: Transferred to expenses (2,106)
Others (2,256)
Ending balance of finished goods (533,234)
Cost of sales of goods manufactured 1,553,147
Add: Beginning balance of merchandise 10,332
Merchandise purchased 33,984
Less: Ending balance of merchandise (16,889)
Transferred to expenses (1)
Others (7)
Cost of sales of goods purchased 1,580,566
Add: Unallocated fixed cost as operating cost 248,788
Cost of raw materials sold 2,468
Inventory scrapped 1,110
Inventory valuation loss on items of cost lower than market price or obsolescence 64,496
Others 8,300
Less: Revenue from scraps (1,358)
Operating Costs $1,904,370

85


SUNKO INK CO., LTD.
9. Statement of Manufacturing Overheads
For the year ended 31 December 2025

Unit: Thousands of NTD

Item Amount Note
Depreciation expense $209,457
Utilities expense 116,277
Indirect labor 99,691
Waste disposal 65,056
Insurance expense 52,986
Fuel cost 45,233
Packaging fee 30,932
Others (Note) 156,762
Subtotal 776,394
Less: Unallocated fixed costs as operating cost (208,069)
Net Amount $568,325

Note: The amount of individual item in others does not exceed 5% of the account balance.

86


SUNKO INK CO., LTD.
10. Statement of Operating Expenses
For the year ended 31 December 2025
Unit: Thousands of NTD

Item Selling and Marketing Expenses General and Administrative Expenses Research and Development Expenses Expected credit gains Total Note
Payroll expense $16,231 $43,938 $22,947 $ - $83,116
Freight expense 6,113 143 55 - 6,311
Insurance expense 1,707 5,579 3,405 - 10,691
Expected credit gains - - - (1,877) (1,877)
Taxes 3,812 54 5 - 3,871
Depreciation expense 69 9,862 5,789 - 15,720
Export/import expense 10,833 - - - 10,833
Professional expense - 13,426 30 - 13,456
Others expense (Note) 11,663 40,648 10,092 - 62,403
Total $50,428 $113,650 $42,323 $(1,877) $204,524

Note: The amount of individual item in others does not exceed 5% of the account balance.

87